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Stroke, also known as a cerebrovascular accident (CVA), occurs when the arteries 
leading to certain areas of the brain rupture (hemorrhagic stroke) or get blocked 
(ischemic stroke). Without sufficient oxygen supply, brain cells die. Depending on 
the amount of brain tissue damage, the stroke results in weakness or paralysis 
on one side of the body. In neuroscientific terms, a stroke patient has sustained a 
lesion of the descending corticospinal system, a condition collectively termed the 
upper motor neurone (UMN) syndrome.
Stroke is a major public health concern. In Europe, more than 1.1 million stroke 
events happened in the year 2000 and the estimates are that it will happen to 1.5 
million people each year by 2025.1 In the Netherlands, about 41.000 people are 
struck by a stroke annually.2 Half of all the surviving patients make incomplete 
recovery, and half of them need assistance in activities of daily life (ADL).3 About 
77-81% of stroke survivors show a motor deficit of the extremities.4 In almost 66% of 
patients with an initial paralysis, the affected arm remains inactive and immobilised 
due to a lack of return of motor function after six months.5,6 Damage to the UMN 
system is further characterised by both negative and positive motor signs, which 
can result in several individual health related problems. These problems contribute 
to stroke being the second most costly disease amongst the elderly, costs which 
are expected to increase by 40% by 2015.7
Negative and positive motor signs of the UMN syndrome
Negative motor signs (“signs of absence”) after a stroke result from deficient voluntary 
muscle activity. In the hemiplegic arm these signs include muscle weakness, loss 
of dexterity and selective control of movement. For the patient this means that 
he/she is no longer able to selectively activate and control limb segments (in part 
or as a whole). This results in a limited ability to produce voluntary goal-directed 
motor actions. Because of the lack of motor recovery, the involved arm often 
becomes inactive and immobilised. The central nervous system and the muscular, 
vascular and connective tissues systems adapt to this state of immobilisation 
and inactivity.8,9 Positive motor signs (“signs of presence”) result from a variety of 
muscle overactivity types such as clonus, co-contractions and velocity-dependent 
increases in excitability of phasic and tonic muscle stretch reflexes. The latter is 
also known as spasticity. This neurologically induced phenomenon results from 
loss of inhibitory supraspinal control over spinal reflex activity.10 Spasticity can 
affect the trunk, legs and arms. In fact, any of the positive motor signs can more 
or less impede voluntary motor actions, but spasticity in particular is associated 
with impairments in body functions and activity limitations.11,12
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Two significant consequences of spasticity are that the spastic muscle has the 
tendency to remain in a shortened position for prolonged periods of time, and 
that attempted movements are restricted. Prolonged periods of both spasticity 
and immobilization result in the development of biomechanical changes of the 
muscles. These biomechanical changes can predispose a stroke patient to the
development of muscle contractures.13 Muscle contractures are characterized by a 
loss of functional motor units and changes in muscle fibre type. Muscles subject to 
prolonged positioning at a short length, and which are rarely exposed to active or 
passive stretch, also lose sarcomeres as a result of decreased protein synthesis. 
As a consequence, these muscles show an increase in the amount of connective 
tissue and become stiffer.14 These secondary adaptations are particularly evident 
in antigravity postural muscles and appear quickly, have potent negative effects 
on the patient's ability to exercise, train and regain effective performance of motor
actions.15 The long held belief that contracture is a secondary complication of 
spasticity was recently supported by scientific evidence.13  Despite this finding, 
there is still little evidence that decreasing spasticity has a positive effect on
shoulder or arm muscle contractures.(eg 16-18)  Conversely, the fact that hyperactivity
could only be elicited toward the end of range in a muscle with contracture suggests 
that the presence of contracture may be a potentiator of the stretch reflex.19 It is 
also possible that spasticity and muscle contracture are mutually potentiating.20
Hypertonia
An examiner will feel spasticity as a velocity-dependent increase in resistance 
to passive muscle stretch. The muscles most at risk of developing spasticity are 
also those that traditionally develop contractures. Contractures result in stiffer 
muscles, which also introduces an increase in resistance to stretch. Interestingly, 
many patients develop both spasticity and contractures in the shoulder extensors,
adductors and internal rotators.21 In these (and other) muscles, the combination 
of neurological and biomechanical resistance to passive stretch results in an 
impairment that is called hypertonia.
Post-stroke hypertonia has been associated with dependence in every-day 
activities,22 motor impairments, activity limitations,12,23 worse arm motor recovery 
and a longer time to admission for rehabilitation.24 These findings suggest that
hypertonia is an important and well monitored impairment after stroke. However, 
data about the incidence of hypertonia is scarce. Data about the prevalence of 
hypertonia is rather heterogeneous due to differences in patient groups (acute vs. 
chronic/ischemic vs. hemorrhagic stroke), assessment timing (ranging between 
5.4 days and 18 months), methods of assessment (Ashworth Scale25, Modified 
Ashworth Scale26, Tone Assessment Scale27), study design (cross-sectional versus 
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longitudinal) and a multitude of clinical definitions used to define hypertonia.22-24,28,29 
Although some literature reports on how arm hypertonia evolves post-stroke,28,30 
to date little is known about whether hypertonia develops differently in specific 
subgroups of patients and whether it's development can be predicted. Another 
problem is that, clinically, the neurological (i.e. spasticity) and biomechanical (i.e. 
contracture) contributions to hypertonia cannot easily be distinguished. This does 
not allow clinicians and therapists to offer their patients tailored treatment, since 
this requires discrimination between the neural and tissue related components of 
hypertonia. Further research in this area would not be amiss.
Hemiplegic shoulder pain
Generally, hemiplegic shoulder pain (HSP) or post-stroke shoulder pain is prevalent 
in approximately 22-23% of the general population of stroke survivors,31 and in 
almost 54% of patients in rehabilitation settings.31,32 Much uncertainty exists as 
to the specific causes for the development of HSP. Since HSP is associated with 
reduced quality of life33 and restricts patients’ daily lives,34 there is an urgent need 
to investigate the causes of HSP and interventions aimed at the prevention of 
HSP. Despite some contradicting findings, growing evidence exists indicating 
that spasticity might be the main cause of HSP.35 Furthermore, loss of range of 
motion due to contracture is also associated with the occurrence of HSP.36-40 The 
latter findings together suggest that there are bidirectional relationships between 
spasticity, contracture and HSP. This raises the question whether influencing
either spasticity or contracture could result in a change in HSP.
Evidence based interventions for post-stroke spasticity, contracture and 
shoulder pain 
Several interventions improve arm function after stroke and prevent secondary 
impairments.eg.41-43 However, many of these interventions are not suitable for 
patients with severe motor deficits because these require ‘active’ residual arm 
motor capacity. Although literature does not provide a clear definition of “severe 
motor deficit”, post-stroke recovery trends indicate that those who have the 
poorest level of recovery score around 18 points on the arm section of the Fugl-
Meyer Assessment (FMA)44 in the chronic phase post-stroke.45,46 Especially in 
these patients the chances of arm recovery are diminished, and the development 
of hypertonia ('spasticity')22,30   and contractures8,47 are increased. These patients 
often lack the minimal motor abilities required to engage in interventions such 
as computerized arm training48 or constraint-induced movement therapy.49,50 
Therefore, ‘passive’ interventions are needed to prevent secondary impairments 
and optimise long-term handling and assistive use of the affected arm.
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In this thesis, the underlying bidirectional relationships between spasticity, 
contracture and HSP served as a theoretical framework to try and prevent the
development of contracture after stroke with the aim of simultaneously preventing 
the development of hypertonia, spasticity and shoulder pain. Literature describes 
several of such 'passive' interventions. For example, a seemingly appropriate
'passive' intervention for patients with muscle overactivity (or abnormal muscular 
contractions such as spasticity) is the use of botulinum toxin.51,52 However, 
botulinum toxin is only prescribed after spasticity has emerged53 or poses a direct 
health-related problem for a patient. To date, there is no solid evidence that 
it can be used to directly influence the neural component of hypertonia in the
earliest stages after stroke. Improvements in spasticity have also been seen in the 
use of repetitive transcranial magnetic stimulation (rTMS).54,55 As promising as this
recent intervention may seem, more work is needed to investigate the merits of this 
approach. Two other 'passive' interventions which appear to be appropriate are
static arm muscle stretching programmes and neuromuscular electrical stimulation 
(NMES).
Static muscle stretching and neuromuscular electrical stimulation
The proactive application of specific arm muscle stretching programmes after 
stroke (i.e. to stretch the arm muscles prone to shortening for longer periods of 
time per day) was first recommended by Ada and Canning.56 They derived their 
idea for this intervention in part from animal research, which showed that sustained 
passive muscle stretch resulted in an increase in sarcomere number.57 Although 
the study of mechanisms of muscle contracture in humans is rather difficult, it has 
been assumed that muscles of humans undergo similar adaptations.58 The results 
of the first study regarding the efficacy of such a static arm muscle stretching 
programme in patients after stroke were inconclusive,59 thus meriting further 
research.
Investigations of the application of cyclic NMES60 after stroke showed that it can 
be used to reduce glenohumeral subluxation61,62 and reduce muscle resistance63 
resulting from reciprocal inhibition.64-66 NMES can also be used as an electrically 
induced stretching exercise. This 'passive' exercise can improve pain-free range 
of passive humeral lateral rotation,61 although reviewers have concluded that this 
is the only significant benefit.67 Unfortunately it is unknown whether these results 
apply to patients with poor recovery of arm function, and whether it is easier to 
stretch (hypertonic) muscles in conjunction with NMES. In view of the reported 
benefits of NMES it may be worthwhile to investigate the effects of a static arm 
muscle stretching programme combined with NMES.
1 1
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Reliability of passive range of arm motion measurements
To assess and evaluate the arm function of patients after stroke, clinicians and 
researchers can use a wide variety of assessment tools. Of these, goniometry 
gives insight into the active (AROM) and passive (PROM) range of joint motion. 
Unfortunately, little specific information about goniometric measurements in 
patients after stroke can be found in literature.
In patients with severe arm motor deficits after stroke, the degree of passive
shoulder external rotation, abduction and wrist extension are regularly used 
as outcome measures to evaluate the effects of interventions.eg. 67-69  First of all, 
valuable conclusions about changes in PROM can only be drawn when these 
measurements are reliable. Reliability of arm ROM measurements was shown to be 
good in healthy subjects70,71 and in patients with orthopedic conditions.72,73 These 
findings cannot simply be generalised to patients who have suffered a stroke since 
a large portion develop contractures, hypertonia, spasticity and shoulder pain. 
These impairments in body functions can hinder the rater's attempts to move the 
hemiplegic arm, and may increase the chance of making measurement errors. 
Performance of PROM measurements by one rater only may also increase these 
errors because simultaneously handling a paralyzed arm, the goniometer and 
reading the score is difficult. Identifying and quantifying these sources of variation 
is important in order to find strategies to reduce their influence on outcomes.74
Goniometric measurements of arm joints in patients after stroke reflect both the true 
range of a joint and measurement errors caused by different sources of variation. 
In general, a useful indicator to express real, non-error change in an outcome 
measure is the smallest detectable difference (SDD). In the case of goniometry 
for example, the SDD offers clinicians and scientists information as to whether a 
difference in PROM (over time) is due to random measurement error, or actually 
represents a true difference or change in their patients’ PROM. Ideally, a difference 
in PROM from the start to the end of a treatment period should at least exceed the 
SDD to be able to conclude with 95% certainty that the PROM has really changed 
over time. Similarly, in addition to a statistical significant difference, a difference in 
PROM between an experimental and a control condition should exceed the SDD 
for the intervention to be called superior to the control condition. This knowledge 
can also serve to evaluate the benefit of a treatment based on individual patient 
improvement relative to both cost and risk of complications.75 To date there is a 
dearth of literature regarding the reliability of PROM measurements in patients 
after stroke. Not only information regarding smallest detectable differences is
lacking, but also regarding factors that might potentially influence hemiplegic arm 
PROM measurements. As a consequence, each time PROM results are presented, 
the question remains as to whether such measurements were reliable, reflect the 
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true change in PROM (instead of measurement error) and were influenced by 
different stroke-specific sources of variation. Therefore, these topics need to be 
investigated.
Outline of the thesis
In this thesis, the results of a cohort study and two multicenter randomized 
controlled trials (RCT’s) that were designed and performed between 2002 and 
2011 are presented. The aim of the cohort study, as described in Chapter 2, was 
to analyse the development of hypertonia in the hemiparetic elbow flexors, and to
explore the predictive value of arm motor control on hypertonia in 50 first-ever stroke 
survivors in their first six months post-stroke. Because secondary complications 
such as hypertonia can have detrimental effects on hemiplegic arm use, shoulder 
pain and quality of life, several authors suggested that specific preventive static 
arm muscle stretching programmes should be incorporated into the rehabilitation 
therapy programme. The main aim of the RCT’s that are presented in this thesis 
was to explore whether the clinical application of two such static arm muscle 
stretching programmes during rehabilitation could prevent the development of 
secondary impairments in patients after stroke with very poor arm motor control. 
In the first pilot RCT, the efficacy of a single-modality static arm muscle stretching 
programme was investigated. The results of this RCT will be presented in Chapter 
3. The findings of this pilot trial, combined with findings from literature, gave clear 
reasons to investigate a similar static arm muscle stretching programme using a 
higher intensity of stretch. To achieve this, neuromuscular electrical stimulation was 
used as an adjunct to stretching. The results of this multimodal RCT are described 
in Chapter 4. During both RCT’s, the passive joint ranges were assessed by two 
blinded observers. This not only presented the opportunity to report on interrater 
reliability, but also to generate information about smallest detectable differences 
and factors that were associated to, or influenced, the PROM measurements. The 
results of these studies will be described in Chapter 5 and Chapter 6. Finally, 
Chapter 7 contains the general discussion in which the results of the studies 
are integrated, the strengths and limitations of the studies are addressed and 
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To analyze the development of hypertonia in the hemiparetic elbow flexors, and 
to explore the predictive value of arm motor control on hypertonia in a cohort of
first-ever stroke survivors in the first six months poststroke.
Design
A prospective cohort study.
Setting
A cohort of stroke survivors from a large, university-affiliated hospital in The 
Netherlands.
Participants
Patients (n = 50) with first-time ischemic strokes and initial arm paralysis who were 




At 48 hours, 10 to 12 days, three and six months poststroke, hypertonia and 
arm motor control were assessed using the Modified Ashworth Scale and the
Fugl-Meyer Assessment arm score.
Results
The incidence rate of hypertonia reached its maximum before the third month 
poststroke (30%). Prevalence was 42% at three and six months. Participants 
with poor arm motor control at 48 hours poststroke were 13 times more likely to
develop hypertonia in the first six months poststroke than those with moderate to 
good arm motor control. These results were not confounded by the amount of arm 
function training received.
Conclusions
Hypertonia develops in a large proportion of patients with stroke, predominantly 
within the first three months poststroke. Poor arm motor control is a risk factor for 
the development of hypertonia.
Key Words




Annually, 15 million people worldwide have a stroke. Five million of them are left 
permanently disabled, placing a burden on both family and community.1 In almost 
66% of the stroke survivors with initial motor deficits, the affected arm remains 
without function after six months.2,3 Because of this lack of function, the patient’s 
affected arm remains inactive and immobilized. Over time, the central nervous 
system and (connective) tissues of the arm adapt to this state of inactivity,4,5 often 
resulting in residual impairments such as contracture and hypertonia.
Poststroke hypertonia (increased resistance to passive stretch) has been 
associated with dependence in everyday activities,6 motor impairments, activity 
limitations,7,8 worse arm motor recovery, and a longer time to admission for 
rehabilitation.9 Ideally, knowledge about epidemiologic data concerning hypertonia 
and its associated prognostic variables might help physiatrists and therapists to 
recognize how often it occurs and which patients are at greater risk of developing 
hypertonia so that preventive measures could be taken in daily clinical practice. 
However, data about the incidence of hypertonia are scarce, and until recently, 
only few postacute prognostic variables could be identified as a risk factor 12 
months after stroke.10,11  Besides that, the available data about the prevalence are 
rather heterogeneous because of differences in patient groups (acute vs chronic/
ischemic vs hemorrhagic stroke), assessment timing (ranging between 5.4d and 
18mo), assessment methods (Ashworth Scale, Modified Ashworth Scale, Tone 
Assessment Scale), study design (cross-sectional vs longitudinal), and the clinical 
definitions of hypertonia.6,7,9,12,13  Moreover, because hypertonia may fluctuate over 
time in about 5% to 7.5% of the patients,7,12,14 data from cross-sectional studies 
may underestimate or overestimate the prevalence of hypertonia.The two major 
contributors to hypertonia are reflex hyperexcitability and the passive mechanical 
properties of the muscle (contracture).15 A more serious degree of upper motor 
neurone damage (ie, a larger stroke) results not only in less recovery16 but also 
in the development of significantly more clinical manifestations such as reflex 
hyperexcitability.17 In addition, full arm paralysis or severe paresis is likely to result 
in learned nonuse18 of the hemiplegic arm, increasing the chance of contracture 
development. Since the combined effects of reflex hyperexcitability and contracture 
can cause increased resistance to passive stretch, one may expect that patients 
with stroke who have the most severe brain damage (and hence the poorest level of 
recovery of arm motor control) are more at risk for the development of hypertonia. 
Although some literature reports on how arm hypertonia evolves poststroke,12,19 
to date little is known about whether hypertonia develops differently in specific 
subgroups of patients. To test this hypothesis, subgroups have to be formed 
based on level of arm motor control. Findings from two recent studies showed 
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that patients with severe arm paresis had 1019 to 226 times higher odds of having 
hypertonia at one month and one year poststroke, respectively, compared with 
patients with no and moderate paresis. However, in both studies, hypertonia was 
deemed present if resistance to passive movement was felt during any of eight 
different passive arm movements performed, which gives little detail about which 
muscles are most prone to hypertonia development. Moreover, one study6 was 
a cross-sectional survey one year after stroke, presenting results from which it 
is difficult to predict who is (most) at risk of developing hypertonia and who may 
benefit from preventive intervention early after stroke onset. Collecting prospective 
data from single arm muscle groups would facilitate more accurate predictions.
The aim of this study was twofold: (1) to analyze incidence and prevalence of 
hypertonia in the hemiplegic elbow flexors during the first six months poststroke 
and (2) to analyze the influence of motor control and time on the development of 
hypertonia. We hypothesized that (1) stroke survivors with poor recovery of motor 
control were more at risk for the development of hypertonia than those with a 
better level of recovery, and (2) the longer the period after stroke, the greater the 
risk for hypertonia.
Method
Participants and Study Design
The current study was part of a cohort study on the predictive value of transcranial 
magnetic stimulation (TMS) for recovery in ischemic stroke (M.H. Hoonhorst, 
unpublished data, 2011). The original cohort, 73 patients with first-ever ischemic 
strokes who were admitted to a specialized stroke unit of a large university-
affiliated hospital (Isala Clinics, Zwolle, The Netherlands), was recruited between 
August 2005 and February 2008. Eligible participants were those who were 
unable to elevate the arm while lying in a supine position, unable to voluntarily 
move the fingers during the first physical screening, or both. After confirmation 
of the diagnosis by computed tomography or magnetic resonance imaging scan, 
the patient had to be hospitalized within the first day after the onset of symptoms 
and had to show a unilateral paralysis or significant paresis of the arm (Medical 
Research Council score, 0-3). Patients were excluded if they had severe loss of 
consciousness, were comatose, terminally ill, unable to receive neurorehabilitation 
because of severe comorbidity, or if contraindications for TMS were present.20 
In addition, patients without clear motor deficits within 24 hours of stroke onset 
(resulting from a transient ischemic attack) as clinically judged by the neurologist 
were also excluded. Each participant was assessed within 48 hours (t1), after 10 
to 12 days (t2) and after three (t3) and six (t4) months postonset. All participants 
or close relatives gave written informed consent. The study was approved by the 
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local medical ethics committee.
Clinical Assessments
At baseline (t1), the participants’ characteristics (age, sex, affected side) and 
Barthel Index scores were collected. Hypertonia was assessed using the six-
point Modified Ashworth Scale (MAS),21 which is a valid indicator of resistance to 
passive stretch.15 During administration of the MAS, the participants were seated 
in a comfortable position with their forearms in supination. Participants were 
instructed to relax while the rater first passively moved the forearm from full flexion 
to full extension to determine the available range of motion. This was done slowly 
so as not to elicit any reflex activity. Then the same movement was repeated in 
approximately one second by counting “one thousand and one” to rate the actual 
resistance to passive movement. Clinically relevant hypertonia was operationally 
defined as an MAS score of at least 1+ (slight increase in muscle tone, manifested 
by a catch, followed by minimal resistance throughout the remainder [less than 
half] of the range of motion). Motor control of the hemiplegic arm was assessed 
using the 66-point arm section of the Fugl-Meyer Assessment (FMA).22 The FMA 
has an excellent reliability, has good construct validity23,24 and is highly responsive 
for changes in motor function after stroke.25 We considered participants with an 
FMA score of 18 points or less as having poor motor control, and participants 
with more than 18 points as having moderate to good motor control. During the 
t2, t3, and t4 assessments, participants were additionally asked to report their 
weekly frequency of occupational therapy (OT) and physical therapy (PT), and 
whether arm function training (yes or no) was part of the treatment program in the 
weeks before the assessments. All assessments were performed in the hospital 
or outpatient location by the same rater (M.H.H.). 
Statistical Analyses
Descriptive statistics were used to report participant characteristics at baseline. 
Incidence proportion (number of participants developing hypertonia during 
a time period/total number of participants at risk observed during that period) 
andprevalence (total number of participants showing hypertonia/total number 
of participants) were calculated for t1, t2, t3 and t4. At these time points, the 
frequency of OT and PT, and the number of participants receiving arm function 
training were compared between the two arm function groups (poor arm function 
vs moderate/good arm function) by using an independent t-test and a chi-square 
test, respectively. To estimate the predictive value of poor motor control and days 
after stroke for the development of hypertonia during the first six months, we 
dichotomised the MAS scores (MAS ≤1 and MAS ≥1+) and subsequently performed 
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a logistic generalized estimating equations (GEE) analysis by using an exchangeable 
correlation structure. With logistic GEE we predicted the dichotomous outcome 
variable (MAS) on the basis of a binary predictor variable (FMA ≤18 points at t1, 
yes or no) and an interval predictor variable (days after stroke), while correcting 
for dependency of the data within a participant (repeated assessments over time). 
The interaction between motor control and time was explored whereby time was 
recoded into days after stroke (t1-t4: 2, 11, 90 and 180 d, respectively). For all tests 
the two-tailed significance level was set at .05. All analyses were performed using 
SPSS (version 16).
Table 1   Characteristics of participants with a first-ever ischemic stroke at baseline (n = 50).
Characteristics
Age (y) 70.3 ± 12.3
Sex (M/F) 21/29
Paretic side (L/R) 26/24
Barthel Index 5 (2-8.3)
Values are mean ± SD, n, or median (interquartile range).
Abbreviations: F, female; L, left; M, male; R, right.
Results
Of the initial 73 participants, 22 died and one was lost to follow-up (M.H. 
Hoonhorst, unpublished data, 2011), leaving 50 participants for data analysis. 
Their baseline characteristics are shown in Table 1. Figure 1 shows how hypertonia 
(the MAS scores) developed over time. Hypertonia incidence rate reached its 
maximum (30%) between t2 (10-12 d after stroke) and t3 (three mo after stroke); 
thereafter the incidence decreased. At six months poststroke (t4), 21 participants 
(42%) had hypertonia (MAS ≥1+), of whom four (8%) showed a transient course.
Table 2   Overall values of FMA armscores and percentages of participants with an FMA score of ≤18 points and >18 
points at 48 hours (t1), after 10 to 12 days (t2), after three (t3) and six (t4) months.
FMA (n = 50) t1 t2 t3 t4
Median (IQR) 8.5 (3–50.5) 17 (4–58) 51 (5.75–63) 53 (6–64)
≤18  points 60% 52% 38% 36%
>18  points 40% 48% 62% 64%
Abbreviations: IQR, interquartile range.
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Figure 1   Flow chart depicting the development of hypertonia (MAS =1+), incidence proportions, and prevalence 
rates in/of 50 participants during the first six months poststroke. Solid arrows represent participants who developed 
permanent hypertonia. Dotted arrows represent the four individuals who showed a transient course of hypertonia.
Abbreviations: I, incidence proportion; P, prevalence rate; t0, prestroke; t1, at 48 hours; t2, at 10-12 days; t3, at three 
months; t4, at six months. a Number of participants who develop hypertonia for the first time.
Table 2 shows that 40% of the participants already had more than 18 points on 
the FMA at t1. This percentage increased to 64% at t4. At six months postonset, 
36% of the participants had 18 points or less on the FMA, and their median FMA 
scores never exceeded a total of 5 points. In the other subgroup, recovery of arm 
motor control seemed to have stabilized at about three months poststroke with a 
median of 61 points. Between the two FMA-subgroups, no significant differences 
(p-values ranging from .074 and .98) with regard to the frequencies of OT and PT 
were found for any of the time points (Table 3). The total frequencies per group 
were also not  significantly different (calculations not shown). Table  3 further shows 
that only 0% to 4% of the participants with more than 18 points on the FMA 
received arm training from physical therapists. Occupational therapists continued 
arm treatment in most participants irrespective of level of arm function until t3. 
After t3, only 13% of the participants with 18 points or less on the FMA continued 
receiving arm training from occupational therapists. Results from the GEE (Table 4) 
revealed that an FMA score of 18 points or less was a significant predictor for the 
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presence of hypertonia; these participants were 12.8 (95% confidence interval [CI], 
3.5-47.3) times more likely develop hypertonia (MAS ≥1+). Days after stroke (time) 
also was a significant predictor of hypertonia; per day beta increased with .011. 
The interaction between motor control and time was not significant (p = .58).
Table 3   Between group comparison of possible confounders of arm hypertonia between 48 hours and six months 
poststroke. 
t1-t2 t2-t3 t3-t4
FMA ≤18 FMA >18 FMA ≤18 FMA >18 FMA ≤18 FMA >18
PT frequency
(sessions/wk)




2.89 ± 1.05 
(n = 19)
3.07 ± 1.08 
(n = 30)
2.11 ± 0.96 
(n = 18)
2.10 ± 1.35 
(n = 31)
Participants receiving 
















2.62 ± 0.65 
(n = 24)
2.95 ± 0.58 
(n = 22)
2.33 ± 1.09 
(n = 18)
2.54 ± 1.14 
(n = 26)
1.28 ± 1.07 
(n = 18)
1.27 ± 1.46 
(n = 30)
Participants receiving














Note: Values are mean ± SD or as otherwise indicated. n does not add up to 50 because of missing data. Abbreviations: 
PT, physical therapy; OT, occupational therapy; SD, standard deviation; FMA, Fugl-Meyer Assessment armscore. 
a Significantly (X2, Fisher exact test p<.05.) less OT from t3-t4 and more PT at all occasions for participants with poor 
motor control (FMA ≤18 points).
Table 4   Prediction of hypertonia (MAS ≥1+) in the first six months poststroke.
Predictors Beta SE Sig. OR (95% CI)
Poor arm motor control at t1 2.55 0.67 <.001 12.78 (3.46-47.25)
Days after stroke 0.011 0.004 .003 1.01a (1.00-1.02)
Constant -3.17 0.56 <.001 0.04 (0.01-0.13)
Note. Results from generalized estimating equations (n = 50)
Abbreviation: SE, standard error; Sig., significance; OR, odds ratio; 95%CI, 95% confidence interval.
a It may seem that the effects of time can be neglected since the OR is 1.01 per day, but the influence of, for example, 
30 days is considerable, resulting in an OR of 1.4= e (30 * 0.011).
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Discussion
To our knowledge, this is the first longitudinal study describing in detail both the 
incidence and the prevalence of elbow flexor hypertonia in the first six months 
poststroke, as well as the predictive value of arm motor control on its development. 
The incidence rate of hypertonia reached its maximum before the third month 
poststroke (30%). A large portion (42%) of the participants had hypertonia at and 
six months postonset. The present study also shows that participants with poor 
motor control (ie, ≤18 points on the FMA) at 48 hours poststroke were 13 times 
more likely to develop hypertonia in the first six months poststroke than those with 
FMA scores of more than 18 points. Arm function training did not confound these 
findings. Additionally, the risk of developing hypertonia increased significantly over 
time.
Study Limitations
Some limitations of this study have to be addressed. First, only elbow flexor
hypertonia was assessed using the commonly used MAS. Although there is
considerable debate about the clinimetric properties of the MAS, several studies26-28
have shown that its reliability is sufficiently high (eg, weighted kappa = .84 for 
interrater and .83 for intrarater comparisons27) when used to assess hypertonia in 
the elbow joint. However, because elbow flexors are not the only arm muscles prone 
to the development of hypertonia, the prevalence and incidence of hypertonia of 
the affected arm after stroke may have been underestimated in the current study.
Second, because we dichotomized the MAS-scores, comparisons with the 
findings of other investigators may be hindered. We argue that clinically, MAS 
scores of 1 or less are not relevant, and patients with these scores do not receive 
interventions aimed at decreasing hypertonia. Further, in our opinion, the “catch 
and release” phenomenon as part of score 1 of the MAS is caused by a level of 
reflex hyperexcitability incapable of causing contracture. In addition, to be able to 
distinguish between no and clinically relevant hypertonia, the rater has to be able to detect 
clearly the differences in resistance to movement. When hypertonia was quantified 
biomechanically, subjects with an MAS of 1+ proved to have significantly higher
resistance to passive movements than subjects with an MAS of 0 or 1,29 which 
may be a prerequisite to detect these differences. However, in later research, 
differences in resistance between grades 1, 1+ and 2 could not be confirmed.30 
Future research is warranted to solve this issue. Third, only data of surviving 
participants were included in the analysis because they completed all assessments 
needed for the prediction model. Probably these participants had less extensive 
strokes than those who died in the course of the study. This selection probably 
resulted in an underestimation of incidence and prevalence data. Finally, the 
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amount of arm function training participants received from occupational and 
physical therapists during their participation did not confound the outcomes under 
study, but because some data were missing, the influence of arm function training 
needs further investigation in future studies.
In our study sample, the incidence rate of elbow flexor hypertonia was low at 48 
hours and at 10 to 12 days (10%-13%), and reached a 30% maximum at three 
months post stroke with an additional 7% after six months. The prevalence steadily 
increased from 10% to 20% in the first 10 to 12 days to a maximum of 42% at three 
and six months poststroke. Comparison of these results with those of others (who 
claimed to have assessed spasticity, but who used the MAS and thus assessed 
hypertonia30) is hampered by differences in methodology. In a frequently cited 
prospective study by Sommerfeld et al.7 (n = 95), an incidence rate of 21% was 
found at 5.4 days after stroke. Three months after stroke an incidence rate of 3% 
was found. The prevalence was 19% at that time. Their higher initial incidence 
rate could be explained by the cutoff point applied (MAS >0) and because the 
assessment was not limited to the elbow joint only. However, if this argument 
would be true, a higher incidence and prevalence would also be expected at three 
months poststroke in that study. More recently, a 4% incidence rate of hypertonia 
(MAS ≥1) at 2 to 10 days poststroke was reported. The prevalence was 23% at 
six months poststroke.19 Since the cutoff point for hypertonia was lower than in 
our study, the differences between our studies cannot be explained adequately. 
Yet another definition of hypertonia (Ashworth Scale ≥2) was applied in a study12 
where hypertonia in the elbow and wrist was observed at time points similar to 
those of our study. The overall incidence rate in that study was very high: 63%. 
This high rate probably occurred because the most severely affected patients 
(suffering from first-ever or previous strokes) were selected in order to increase the 
chance of identifying risk factors for early or persistent hypertonia. Although no 
correlation was found between “early” hypertonia and previous stroke in that study, 
confounding (hypertonia from a previous stroke) may have affected the results. We 
therefore argue that it is best to only select patients with first-ever strokes.
The diversity in patient selection, joint assessment, moments of evaluation, and 
cutoff points for hypertonia illustrates the difficulty of comparing the different 
research results. Therefore a general overview of how many patients with stroke 
develop hypertonia can still not be given. What does seem clear, however, is that 
hypertonia develops predominantly within the first three months poststroke12,14 
and that it has a transient course in a small subgroup of patients.7,12,14,19 We also
observed these two patterns in our sample, resulting in a maximum incidence rate 
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and prevalence of 30% and 42%, respectively, and a transient course of hypertonia 
in 8% of our participants. This latter feature of hypertonia stresses the need for 
studying not only prevalences but also incidence rates by means of longitudinal 
study designs from the acute phase on.
To be able to analyze the influence of the level of motor control on the development 
of hypertonia, we divided our participants into two distinct FMA groups. We used 
an 18-point cutoff score because poststroke recovery trends indicate that those 
who have the poorest level of recovery score around 18 points in the chronic phase 
poststroke31,32 and a score of less than 19 points within four weeks poststroke 
is a strong indicator for poor outcome at six months.33 By applying this cutoff 
score we managed to make a clear distinction between those with poor arm motor
control (typically showing only hyperreflexia and mass synergy patterns of 
shoulder internal rotation, finger and elbow flexion) and those with moderate to 
good motor control. In the current study, the poor recovery group represented 
60% of the 50 participants at 48 hours and 36% at six months poststroke. During 
their participation, all participants received a comparable amount of OT and PT.
Participants with the poorest level of arm motor control kept receiving arm PT 
onto six months poststroke. A comparable number of participants in both arm 
function groups received OT, which was discontinued in the poor function group 
only after arm motor control had stabilized at three months poststroke. This led us 
to conclude that arm training did not confound hypertonia development. However, 
one could instead argue that hypertonia was aggravated by the arm function 
training, a hypothesis that would require further investigation.
Results from our analysis showed that time was a significant contributor to hypertonia 
development. This was not surprising because both reflex hyperexcitability 
(resulting from reorganization within the central nervous system) and contracture 
(resulting from secondary soft tissue changes) need time to develop.17 Although 
the resulting odds ratio (OR) suggests that the effect of time could be neglected 
(1.01 per day), the influence of, for example, 30 days is considerable, resulting 
in an OR of 1.4 = e(30 * 0.011). Participants with poor arm motor control 48 hours
poststroke had a 13 (95% CI, 3.5-47.3) times higher OR of developing hypertonia in the
subsequent six months compared with those with moderate to good motor control. 
This result is in concordance with an OR of 10 (95%CI, 2.1-48.4) found in a nearly 
similar sample,19 despite another definition of hypertonia (MAS ≥1 in any of four arm 
joints). In another study,6 an OR of 22 (95%CI, 3.9-125) was found in a subgroup 
of participants with the most severe paresis. Despite our smaller sample size, our 
95% CIs for the estimated ORs were smaller. Maybe our study sample was more 
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homogenous with respect to level of arm motor control. However, this assumption 
cannot be verified because of differences in arm motor control assessment. 
To analyze the effect of the cutoff point for the FMA, we performed a post hoc 
sensitivity analysis. The resulting ORs for poor motor control were 14.5 and 9.3 
when using an FMA cutoff point of 9 and 36 points, respectively. These results 
indicate that the level of the cutoff point has an influence on the outcome, but they 
also show that the FMA is a fairly robust predictor of hypertonia development.
Our findings have shown that elbow flexor hypertonia develops in a considerable 
subgroup of patients with stroke. Our findings also imply that as early as 48 hours 
poststroke, one can predict who is most at risk for hypertonia development based 
on the FMA score. This knowledge might serve physiatrists and therapists to inform 
their patients about the risk of developing hypertonia. It might also serve therapists 
to take appropriate preventive actions (although a tailored treatment would require 
more detailed discrimination between the neural and tissue-related components 
of hypertonia). Despite these findings, hypertonia also developed in a number of 
participants with moderate to good arm function, which underscores the need for 
awareness of this impairment in all patients with stroke. As mentioned earlier, two 
of the main factors that contribute to hypertonia are reflex hyperexcitability and the 
passive mechanical properties of the muscle (contracture).15 Reflex hyperexcitability 
may be hard to influence in the early stages after stroke. Physical and occupational 
therapists can, however, prevent contracture development in an attempt to keep 
down the level of resistance to passive movement. Patients with stroke who have 
an FMA score of 18 points or less could, for example, have measures implemented 
to prevent contractures. Such measures are currently not instituted soon enough 
after stroke.34 Future prospective research should be performed to assess whether 
such measures, initiated in the acute phase poststroke, can help to reduce both the 
incidence and the prevalence of hypertonia and its associated features. To obtain 
a valid overall picture of the development of hypertonia, it seems paramount to 
perform more longitudinal research, to only select patients with first-ever strokes, 
to assess single joints separately, and to use similar definitions for hypertonia. 
In addition, it may be valuable to simultaneously assess clinical variables that 
seem to influence or predict the development of hypertonia, and to present raw 
data (Appendix 1) that enables better comparison between studies. Finally, we 
urge future researchers to abandon the use of the word ‘spasticity’ when, in fact, 
hypertonia (resistance to passive stretch) is assessed by using the MAS. This also 
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Appendix 1   Patient raw Fugl-Meyer Assessment (FMA) and Modified Ashworth Scale (MAS) data at 48 hours (t1), 
10 to 12 days (t2), three (t3) and six months (t6) poststroke.
t1 t2 t3 t4
Participant FMA MAS FMA MAS FMA MAS FMA MAS
01 6 0 6 1 40 2 41 2
02 21 0 17 0 59 0 55 1
03 59 0 58 0 65 0 57 0
04 57 0 66 0 63 0 66 0
05 11 0 59 0 66 0 63 0
06 63 0 66 0 66 0 66 0
07 62 0 65 0 66 0 65 0
08 66 0 66 0 66 0 66 0
09 52 0 58 0 51 0 49 0
10 65 0 66 0 66 0 66 0
11 5 1 6 0 6 1 5 1
12 35 0 55 0 55 0 65 0
13 59 0 61 0 63 0 66 0
14 3 1 32 1 27 1 52 1
15 52 0 63 0 64 0 65 0
16 64 0 64 0 64 0 64 0
17 0 0 0 0 6 0 12 0
18 8 0 9 0 6 0 7 0
19 12 1+ 17 1 34 3 38 3
20 5 0 3 0 2 0 1 1
21 3 0 4 0 6 2 8 2
22 5 0 58 0 62 2 64 2
23 2 0 20 1+ 58 2 59 2
24 61 0 61 0 66 0 66 0
25 2 0 4 0 3 1+ 3 2
26 63 0 65 0 65 1+ 65 1
27 4 0 4 1+ 10 2 9 2
28 4 1+ 6 1+ 4 2 6 3
29 9 0 7 1 4 0 4 0
30 2 0 6 1 6 1+ 6 1+
31 12 0 12 0 60 0 62 0
32 5 1+ 31 1+ 36 2 27 2
33 5 1 32 1 61 1 61 1
34 38 1 53 1 65 0 65 0
35 7 0 7 1+ 15 1 22 2
36 2 0 7 0 4 2 2 2
37 39 0 34 0 61 0 59 0
38 3 0 2 1 4 0 4 0
39 0 0 0 0 2 0 6 0
40 26 0 2 0 62 0 61 0
41 0 1 21 2 58 3 64 3
42 4 2 4 2 5 2 5 1
43 50 0 10 0 51 1+ 54 2
44 46 0 1 1 4 1+ 2 2
45 2 0 2 3 2 2 2 2
46 2 0 2 1+ 2 2 2 2
47 3 2 15 3 24 1+ 25 2
48 18 0 57 0 60 0 60 0
49 1 0 1 0 5 1 6 1+
50 42 0 56 0 59 0 59 0
Median 
(IQR)
8.5 (3 – 50.5)
Median 
(IQR)
0 (0 – 0)
Median 
(IQR)
17 (4 – 58)
Median 
(IQR)






0 (0 – 3)
Median 
(IQR)
53 (6 – 64)
Median 
(IQR)
1 (0 – 3)
Note. The FMA arm score ranges from 0 to 66.  Abbreviation: IQR, interquartile range.
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Contracture preventive positioning
of the hemiplegic arm    
in subacute stroke patients:
a pilot randomized controlled trial











To investigate the effectiveness of a contracture preventive positioning procedure 
for the hemiplegic arm in subacute stroke patients in addition to conventional
physio- and occupational therapy.
Design
A single-blind pilot randomized controlled trial.
Setting
Inpatient neurological units from three rehabilitation centres in the Netherlands.
Subjects
Nineteen subacute stroke patients (minus two drop-outs) with a severe motor
deficit of the arm.
Interventions
All subjects underwent conventional rehabilitation care. Nine subjects additionally 
received a positioning procedure for two 30-min sessions a day, five days a week, 
for five weeks.
Main measures
Passive range of motion of five arm movements using a hydrogoniometer and
resistance to passive movement at the elbow using the Ashworth Scale.
Secondary outcome measures were pain at the end range of passive motions, the arm
section of the Fugl-Meyer Assessment and Barthel Index scores for ADL-
independence. Outcome measures were taken after five weeks and additional 
measurements after 10 weeks by two assessors blinded to group allocation.
Results
Comparison of the experimental (n = 9) with the control subjects (n = 8) after five 
weeks showed that additional positioning significantly slowed down development 
of shoulder abduction contracture (p = 0.042, -5.3 degrees versus -23 degrees). 
No other differences were found between the groups.
Conclusions
Applying a contracture preventive positioning procedure for the hemiplegic arm 
slowed down the development of shoulder abduction contracture. Positioning 
did not show significant additional value on other outcome measures. Since the 




Hemiplegic shoulder pain is one of the most frequent complications after stroke.1-5 
Reviews of the literature6-9 provide an overview of the different impairments of 
the shoulder joint and summarize the most effective therapeutic interventions to 
prevent hemiplegic shoulder pain. One of the factors associated with shoulder 
pain seems to be the loss of shoulder range of motion (ROM).2,4,5,10 Poststroke 
contractures, as reflected by the loss of range of motion, are not surprising 
since increasing evidence supports the hypothesis that immobility after stroke is 
associated with changes in muscle due to adaptive mechanical and morphological 
changes in muscle fibres.11,12 The proportion of patients with contracture in the 
hemiplegic arm approximately five months poststroke was reported to be as high 
as 54%.13 In conjunction with contracture, resistance to passive movement14 and 
spasticity develops in some patients.13 Spasticity was found to be present in 26% 
of acute hemiparetic patients and in 28% three months after stroke in the study 
by Sommerfeld et al.15 Spasticity (or more specifically, hypertonus) seems to be 
another cofactor in the development of hemiplegic shoulder pain.6 It is related 
to a decrease in joint passive range of motion16 and correlates both to motor 
impairments15,17 and limitations in activities of daily living (ADL).18
Considering the above discussed impairments in and around the hemiplegic 
shoulder it is hypothesised that prevention of contracture11,12,14,19 and maintaining 
an optimal pain free range of joint motion6 is an important therapeutic intervention 
in stroke rehabilitation. Several authors suggest and describe different methods to 
prevent contracture (i.e. different positioning procedures).11,20
Recently, Ada et al.21 showed for the first time that upper-limb positioning 
prevented shoulder external rotation contracture. However, questions remain as to 
whether recovery of selective arm movements, spasticity, pain and independence 
in activities of daily life (ADL) were affected by this intervention. Therefore, the 
present pilot trial addressed the following questions: Does a positioning procedure 
for the hemiplegic arm prevent (1) contracture as reflected by a decrease in passive 
range of motion and (2) increased resistance to passive movement. Second, does 




A single-blind randomized controlled, multi-centre trial was designed to investigate 
the effectiveness of a well-defined positioning procedure for the  hemiplegic arm 
in subacute stroke patients. Rather than the positioning procedure(s) used in 
previous studies by Dean et al.22 and Ada et al.21 we additionally applied stretch to 
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the elbow flexors. The study was approved by the local medical ethics committee. 
All subjects gave written informed consent prior to participation.
Participants / Subjects
Using a sampling method of convenience, subjects were recruited from three
rehabilitation centres in the Netherlands (Apeldoorn, Doorn and Zwolle). All stroke 
patients admitted between March 2003 (one centre participated as from January 
2004) and January 2005 were initially screened by a physician. 
Subjects had to meet the following inclusion criteria: (1) first ever stroke as defined 
by the World Health Organization23 and maximally 12 weeks poststroke; (2) a
medial cerebral artery stroke, established by means of computerized tomography/
magnetic resonance imaging (CT/MRI); (3) no premorbid impairments of the affected 
arm; (4) no severe shoulder pain; (5) no use of antispasticity drugs; (6) no use of 
pain-reducing drugs except for paracetamol, (7) no planned date of discharge and 
(8) able to give written informed consent. Subjects with fair to good recovery of 
the arm (as defined by Brunnstrom’s stages of recovery 4, 5 or 624 and judged by 
the physician) were excluded. Patients who met the inclusion criteria were then 
referred to a physiotherapist, who administered tests to exclude patients with (9) 
severe neglect (a difference of more than three O’s on the letter cancellation test,25 
severe loss of position sense (scores 2 and 3 on the Thumb Finding Test26,27) 
and cognitive impairment scoring lower than 23 points on the Mini-Mental State 
Examination.28-30 Subjects with aphasia that could not answer the questions 
of the Mini-Mental State Examination were tested by means of the language 
comprehension subitems of the Akense Afasie Test31 (minimum 67 points). Finally, 
patients who were able to prevent contracture by producing voluntary movement, 
having a Fugl-Meyer arm score of more than 18 points on the shoulder/elbow/
forearm subscales,32 were excluded.
Primary outcome measures
Primary outcome measures were (1) passive range of motion using a masked 
fluid-filled goniometer (MIE Medical Research Ltd., Leeds, U.K.) and (2) resistance 
to passive movement using a Dutch translation of the original 5-point Ashworth 
Scale.33
Passive range-of-motion measurements
For standardization purposes of the passive range of motion testing procedures the 
assessors were trained beforehand,34,35 shoulder abduction was applied during 
several shoulder movements34,36,37 and two raters were used simultaneously. The 
first rater carried out one ‘warming-up’ movement prior to the actual passive
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movement, the second rater measured the maximum range with a masked
goniometer. Interrater reliability of the measurement protocol was explored
simultaneously. Intraclass correlation coefficients (ICC type 3,1) were calculated 
for three different datasets, representing the three different evaluations with
respectively 18, 13 and 12 subjects. ICC’s were high, ranging between 0.78 and 
0.99 (detailed procedures and results will be published elsewhere). 
Ashworth grading of resistance to passive movement
Reliability of the original Ashworth Scale in stroke subjects was established 
for the elbow flexors.38 We developed and used a Dutch translation of the
original Ashworth Scale and simultaneously explored the interrater reliability of this
translation. Agreement between our two raters when rating the resistance to
passive extension of the elbow during the three different evaluations was fair to 
moderate (percentages of agreement between 67% and 83%, weighted kappa 
ranging from 0.484 to 0.773). The Ashworth gradings were administered according 
to the recommendations of Bohannon & Smith39 and Koolstra et al.40
Secondary outcome measures
Secondary outcome measures were (3) pain, (4) motor performance of the
hemiplegic arm and (5) independence in ADL. Subjects were asked to report if 
they felt pain at the end range of each passive motion (0 = no pain, 1 = pain). 
Motor performance was assessed using the 66-point arm section of the Fugl-
Meyer Assessment,32 a test that is both valid41,42 and reliable42-45 and assesses the 
subject’s reflexes, the ability to perform 21 different volitional arm movements and 
co-ordination on an ordinal scale. Independence in ADL was assessed using a 
validated and reliable Dutch translation of the Barthel Index.46
Sample size
A pretrial power analysis was conducted using published data of shoulder
external rotation range of motion of the involved shoulder joint in hemiplegic
people.2,4,10,37,47,48 When a power of 80% was used with a standard deviation of 20 
degrees and a significance level of 0.05 (two-sided), 17 participants were required 
for each group.
Procedure
Subjects were randomly assigned to one of the two groups using opaque, sealed 
envelopes containing leaflets with either a capital A (experimental group) or a
capital B (control group). Anticipating a patient drop-out of 10%, a total of 38 
envelopes (19 As, 19 Bs) were distributed over three separate boxes to make 
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sure that both groups were evenly distributed over both arms of the study. An 
independent person carried out the randomization procedure. The envelopes were 
shuffled and drawn blindfolded. Treatment was initiated immediately after baseline
measurement and within one week of the randomization procedure. Outcome 
measurements were taken five weeks later. Final measurements took place ten 
weeks after baseline measurements. The same two raters, unaware of group
allocation and not involved in the treatment of subjects, carried out all the
measurements. Blinding was achieved by reminding the subjects before every 
measurement that they should not reveal allocation to the observers.
Intervention: the positioning procedure
All subjects received ‘conventional’ rehabilitation treatment according to their
clinical need as prescribed by the subject’s primary care rehabilitation physician. 
Additionally, the subjects allocated to the experimental group were asked to carry 
out the prescribed positioning procedure for five weeks, twice a day for half an 
hour on weekdays (a total of 25 h in five weeks). Subjects still admitted after five 
weeks were asked to participate another five weeks for follow-up purposes.
Positioning was carried out by the nursing staff under supervision of trained
research physical therapists who instructed how the positioning procedure should 
be carried out. Care was taken that while moving the arm into position, the shoulder 
was moved with sufficient external rotation to avoid impingement or damage to the 
rotator cuff muscles. The arm was positioned with as much shoulder abduction, 
shoulder external rotation, elbow extension and supination of the forearm as the 
subject could endure without any pain. The arm was always supported by a pillow 
and, if necessary, held in position with a sandbag (Figure 1).
Patients were instructed not to change the position of the trunk to keep the
m. pectoralis major elongated. Nursing staff registered whether the procedure 
was carried out as prescribed and noted possible deviations. Subjects allocated 
Figure 1 The experimental positioning procedure.
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to the control group received no additional therapy or positioning procedures.
‘Contents of treatment sessions’ 
To document the contents of each physio- and occupational therapy session during 
the 10 weeks of the experiment, therapists were asked to complete a checklist 
after every therapy session. The checklist was based upon the International 
Classification of Functioning, Disability and Health (ICF) of the World Health 
Organization.49 By keeping this sort of therapy diary, possible confounding effects 
of the type and amount of (movement) therapy for the arm were recorded.
Statistical analysis
Ratio-level characteristics of subjects in the experimental and control group were 
compared using a Student’s t-test and nominal level characteristics by means of 
a chi-square test. All primary and secondary outcome measures were compared 
at baseline and at five weeks between groups using the Student’s t-test (range of 
motion), Mann-Whitney U-test (Ashworth Scale, Fugl-Meyer Assessment, Barthel 
Index) and a chi-square test (pain score). One subject from the experimental group 
(who fell too ill to participate any further) and one from the control group (who
developed severe shoulder pain and refused further measurements) were not
included in the analyses because of drop-out before the five week measurement
(Figure 2). Results of the 10-week measurements between the groups were not 
analysed statistically due to the small sample size and high drop-out rate. All
statistical procedures were carried out using SPSS for Windows (version 10.0.5). 
Level of significance was set at p = 0.05.
Results
Figure 2 shows the flow of subjects through each stage of the trial. Half of all eligible 
subjects were judged as already having reached Brunnstrom’s fourth stage of
recovery on admission, and were thus excluded. Eventually, only 19 subjects met 
all inclusion criteria and were randomly assigned to the experimental group (n = 
10) or the control group (n = 9). The nine men and eight women who completed 
the study were between 36 and 63 years of age. Eleven out of 17 subjects had 
an affected left side (right hemisphere). Subjects from the experimental group 
started to use the positioning procedure around a mean (SD) of 35.7 (8.2) days 
poststroke. There were no differences between the groups with respect to these 
characteristics. As shown in Table 1, both groups received a comparable total 
amount of time spent on physio- and occupational therapy. The experimental 
group received more physiotherapy and less occupational therapy for the 
hemiplegic arm after five weeks, but the differences were not statistically significant. 
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Figure 2   Flow of subjects through each stage of the RCT from initial screening by
rehabilitation physician to outcome measurement.
 * If subjects were excluded for more than one reason, all reasons were mentioned separately.
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Table 1   Means (standard deviations) of content of treatment sessions and time spent in the positioning procedure 
at five weeks.
At five weeks
                                                                              EXP (n = 9) CON (n = 8) P-value
Total of OT (hours) 7 (1.8) 7.1 (3.4)a 0.915
Upper limb OT (hours) 2.1 (1.7) 3.2 (2.4)a 0.282
Total of PT (hours) 11.7 (3.2) 11.6 (2.6) 0.930
Upper limb PT (hours) 1.6 (1.4) 0.9 (0.6) 0.246
Total of positioning (hours) 19.9 (1.9) 0 (0) <0.001
EXP, experimental group; CON, control group; OT, occupational therapy; PT, physiotherapy. 
a Data from 1 control subject missing.
The nine subjects from the experimental group had the hemiplegic arm positioned 
for an average of approximately 20 hours (80% compliance to intervention).
Five week outcome measurements
Mean passive range of all motions were comparable in both groups at entry into the 
study (Table 2). It is of note that the shoulder external rotation and flexion ranges tended 
to be larger in the experimental group, but these differences were not significant. In the 
course of the first five weeks a clear decrease was seen in the range of motion of both 
groups, especially in the shoulder movements. After five weeks, shoulder abduction 
range of motion was significantly greater in the experimental group (p = 0.042). Table 
2 also shows that none of the other movement directions were significantly different 
between the groups. Table 3 shows that the median Ashworth gradings were not 
different between the groups on entry into the study (p = 0.60). Despite a slight increase 
in both groups after five weeks, the differences between the groups did not reach 
significance (p= 0.917). Subjects from the experimental group started out with higher 
median scores on the Fugl-Meyer Assessment than the controls (16 versus 8.5 points), 
but this difference was not significant between the groups. After five weeks the subjects 
from the experimental group improved their ability to make selective movements of the 
hemiplegic arm. The control group on the other hand hardly showed any improvements 
at all. The difference between the groups was significant (p = 0.038). Both groups 
showed improvements in independence in ADL during the five weeks of participation. 
Barthel Index scores did not differ significantly at entry of the study or after five weeks.
Of all participating subjects, approximately 65% reported pain at the end range of 
the shoulder movements and 35% of the elbow and forearm movements. There 
were no significant differences between the groups at this point. The pain at end of
motion the subjects reported in the elbow and forearm hardly changed over the
Variable
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Table 2   Between group comparisons of the mean passive range of motion (SD) and pre-post change scores after 
five weeks.
At baseline At five weeks         Change scores


































































ER, shoulder external rotation; FLX, shoulder flexion; ABD, shoulder abduction; EXT, elbow extension; SUP, forearm 
supination.
first five weeks, but increased for the shoulder movements to approximately 76% 
of the subjects. Again, there were no significant differences between the groups.
Ten week measurements
Having participated for five weeks in the primary study, 10 subjects were able to 
participate for a further period of five weeks. During these five weeks, the remaining 
four subjects from the experimental group received considerably more hours of 
physio- and occupational therapy and had the hemiplegic arm positioned for an 
additional average of 19 hours (76% of compliance to intervention). Added to the 
first five weeks, this made a total of 39 h of positioning (78% compliance to total 
intervention). Ten-week data are shown in Table 4.
Discussion
The aim of this pilot study was to investigate the effectiveness of a contracture 
preventive positioning procedure for subacute stroke patients with a severe motor 
deficit of their hemiplegic arm. Despite this therapeutic intervention, both groups 
showed a clear decrease in the passive range of motion of most arm movements. 
Applying the positioning procedure for five weeks slowed down the development of
shoulder abduction contracture. Descriptive analysis of the 10-week measurements 
showed further decreases of passive range of motion in both groups. No significant 
differences were found between the groups with respect to resistance to passive
stretch at five weeks. Fugl-Meyer Assessment scores in the experimental group
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Table 3   Between-group comparisons of the medians (interquartile range) of the Ashworth Scale, Fugl-Meyer arm 
score and Barthel Index and pre-post change sores after five weeks.














































AS-EE, Ashworth grade for elbow extension; FMA, Fugl-Meyer Assessment arm score; BI, Barthel Index. a Three 
subjects from the experimental group and two from the control group improved to >18 points on the FMA between 
inclusion test and baseline measurement.
Table 4   Means (standard deviations) of the different variables of the remaining 10 subjects after 10 weeks of
positioning.




Total of OT (hours) 17.2 (6.8) 13.9 (7.6)a
Upper limb OT (hours) 6.2 (8) 3.2 (2.8)a
Total of PT (hours) 24.1 (6.7) 20 (3.6)
Upper limb PT (hours) 5.2 (3.6) 0.9 (0.7)
Total of positioning (hours) 38.8 (5.2) 0 (0)
PROM-ER 26.3 (23.7) 5.17 (5.64)
PROM-FLX 121 (27.8) 89.5 (22.7)
PROM-ABD 76 (16.8) 61.67 (8)
PROM-EXT 102.8 (16.1) 88.33 (6.4)
PROM-SUP 60.3 (17.7) 56.3 (16.4)
AS-EE (median ± IQR) 2 (1.25-2) 1.5 (1-3)
FMA (median ± IQR) 40.5 (30.75-45.75) 10 (8-17.25)
BI (median ± IQR) 20 (18.5-20) 18.5 (15.75-20)
PROM, passive range of motion; ER, shoulder external rotation; FLX, shoulder flexion; ABD, shoulder abduction; EXT, 
elbow extension; SUP, forearm supination; AS-EE, Ashworth grade for elbow extension; IQR, interquartile range; 
FMA, Fugl-Meyer Assessment arm score; BI, Barthel Index. a Data from 1 control subject missing.
were already larger on entry into the study, a difference that reached significance 
after five weeks. This trend seemed to continue after 10 weeks for the remaining 
subjects of the experimental group, but was probably biased by baseline differences. 
The percentage of subjects with pain at the end range of the shoulder movements 
remained high in both groups from baseline to 10 weeks. Especially in the first five 
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weeks of the trial the participating subjects of both groups gained more independence 
of ADL function as indicated by the Barthel Index.
One major limitation of this study was that it was underpowered. We aimed to select 
34 sub-acute stroke patients, but after nearly two years the trial had to be terminated 
because of set time limits, leaving only 19 subjects who met all inclusion criteria. 
This suggests that the inclusion criteria were too strict. However, most patients were 
excluded because we considered their arm function as too ‘active’ for a ‘passive’ 
preventive positioning procedure. Therefore, the patients included in this study 
were representative of the target population, confirming the appropriateness of this 
inclusion criterion. Since only stroke patients eligible for clinical rehabilitation services 
were included in this study, persons with severe stroke and/or severe cognitive 
disabilities were excluded, hence reducing the external validity of the study. 
Another possible limitation of the study was that the positioning procedure was 
carried out by several different nurses under the supervision of four physiotherapists 
trained in carrying out the positioning procedure. Regular checks of the positioning 
procedure by an independent assessor would have increased the rigor of this 
methodology. The current procedure however reflected the standard method of 
working in a Dutch rehabilitation center. Compliance to the protocol was not perfect 
(80%) because some subjects went on an early weekend leave.
Prevention of contracture in stroke patients is deemed very important in the stroke 
rehabilitation literature.11,20 Dean et al.22 reported unclear effects of a contracture 
preventive positioning protocol, mainly attributed to limited sample size and 
insufficient dosage. Ada et al.21 found that 30 minutes of daily positioning for four 
weeks significantly prevented shoulder external rotation contracture. Compared to 
the procedures used by Dean et al. and Ada et al. we also stretched the elbow flexors 
using a positioning procedure that was prescribed for 60 minutes each working 
day for five consecutive weeks over and above standard physio-and occupational 
therapy.
As in the study of Dean et al., our subjects started the experimental positioning 
procedure in or around their fifth week poststroke, three weeks later than the 
subjects in the study by Ada et al. Dean et al. found a mean of respectively 11 and 
14 degree decrease in the experimental and control group of shoulder external 
rotation after six weeks of positioning. Ada et al. found decreases of 6.1 and 17.9 
degrees respectively after five weeks. In line with those results, our subjects showed 
not only a 19.2 (experimental group) and 18.4 (control group) decrease in shoulder 
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external rotation, but also decreases in shoulder abduction and flexion. Despite the 
apparent decreases of the range of motion, shoulder abduction was significantly 
larger in our experimental group after five weeks. Given the nearly similar positioning 
procedures to the study of Ada et al., no other explanation can be given for the 
lack of benefit in shoulder external rotation except for the difference in statistical 
power or the differences in fixation, allowing the weight of the lower arm to pull the 
shoulder joint into more or less external rotation. Resistance to passive movement 
of the elbow flexors as quantified by the Ashworth Scale was not influenced by the 
positioning despite the (submaximal) stretching of the elbow flexors.
In this study, motor performance was assessed by the arm section of the Fugl-Meyer 
Assessment. The score on this measure represents the capability of making several 
synergistic movements, and so it is not an objective measure of useful functional 
motor performance. Despite the fact that motor performance recovered significantly 
more in the experimental group, it is unlikely that the passive stretching procedure 
alone led to significant differences in motor performance. The experimental group’s 
higher baseline scores possibly emphasized the motor scores after five weeks. 
The effect of more arm therapy between five and 10 weeks probably biased this 
difference even more. At the start of the study, nearly 65% of all subjects (n = 17) had 
pain at the end range of shoulder motions. This is in concordance with the findings 
of other authors.1,4,5 Five weeks into the study, 76% of all subjects reported pain at 
end of motion and of the remaining 10 participants after ten weeks 83% still reported 
pain. Pain felt at the end range of motion was present and increased in both groups 
during the trial. It is unlikely that this was caused by the positioning procedure. As no 
single subject reported an inconvenience during the positioning procedure it seems 
justified to conclude that this kind of positioning is safe and harmless as long as it is 
performed within the patients’ pain limits.
Fifteen to 30 minutes of daily stretching may be enough for healthy active animal 
muscles to prevent contracture50,51 but positioning procedures for hemiparetic 
arms of stroke patients examined so far at the very most only seem to slow down 
the development of some contracture(s). To uncover larger significant effects, 
maybe the positioning procedure should be applied for more than one hour each 
day. However, we doubt that this is feasible within a clinical rehabilitation setting 
because of all the other time-consuming therapeutic activities during the day.
Slowing down the development of contractures using positioning procedures may 
be a prerequisite for the recovery of arm function, but we argue that combinations 
of more types of treatment are needed to have more impact on hemiplegic arm 
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recovery. Especially stroke patients with very poor arm function could benefit 
from combined preventive measures since they have limited abilities to ‘actively’ 
train their hemiplegic arm. Positioning procedures in conjunction with the use of 
electrical stimulation, for example, could be one such measure. Future randomized 
trials with larger sample sizes need to be performed to be able to support either a 
single- or multimodality treatment hypothesis.
Conclusion
We set out to investigate if a positioning procedure for the severely affected 
hemiplegic arm prevented contracture as reflected by a decrease in passive range 
of motion. We found some, but no solid evidence that a five-week positioning 
procedure slowed down the development of shoulder abduction contracture. 
Positioning had no clear influence on motor performance of the arm, resistance 
to passive movement of elbow flexors (‘spasticity’), pain at the end range of five 
different arm motions and ADL-independence. In conclusion, preventive effect 
of a single-modality positioning procedure in addition to conventional physio- 
and occupational therapy still remains unclear for patients more than five weeks 
poststroke. 
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Combined arm stretch positioning and
neuromuscular electrical stimulation during 
rehabilitation does not improve
range of motion, shoulder pain or
function in patients after stroke:
a randomised trial











Does static stretch positioning combined with simultaneous neuromuscular electrical 
stimulation (NMES) in the subacute phase after stroke have beneficial effects on basic 
arm body functions and activities?
Design
Multicentre randomised trial with concealed allocation, assessor blinding, and intention-
to-treat analysis.
Participants
Forty-six people in the subacute phase after stroke with severe arm motor deficits 
(initial Fugl-Meyer Assessment arm score ≤ 18).
Intervention
In addition to conventional stroke rehabilitation, participants in the experimental 
group received arm stretch positioning combined with motor amplitude NMES for 
two 45-minute sessions a day, five days a week, for eight weeks. Control participants 
received sham arm positioning (ie, no stretch) and sham NMES (ie, transcutaneous 
electrical nerve stimulation with no motor effect) to the forearm only, at a similar 
frequency and duration.
Outcome measures
The primary outcome measures were passive range of arm motion and the presence 
of pain in the hemiplegic shoulder. Secondary outcome measures were severity of 
shoulder pain, restrictions in performance of activities of daily living, hypertonia, 
spasticity, motor control and shoulder subluxation. Outcomes were assessed at 
baseline, mid-treatment, at the end of the treatment period (8 weeks) and at follow-up 
(20 weeks).
Results
Multilevel regression analysis showed no significant group effects nor significant time 
× group interactions on any of the passive range of arm motions. The relative risk of 
shoulder pain in the experimental group was non-significant at 1.44 (95% CI 0.80 to 
2.62).
Conclusion
In people with poor arm motor control in the subacute phase after stroke, static stretch 
positioning combined with simultaneous NMES has no statistically significant effects 




Stroke, upper extremity, muscle stretching exercises, electrical stimulation, activities of 
daily living, randomized controlled trial.
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What is already known on this topic
Contracture of muscles in the arm after stroke is common. Stretch alone does 
not typically produce clinically important reductions in contracture in people 
with neurological conditions. Hypertonia may limit the application of stretch and 
therefore its potential benefits.
What this study adds
In people with poor arm motor control after stroke, static arm positioning to 
stretch muscles prone to contracture combined with neuromuscular stimulation 
of the antagonist muscles did not have significant benefits with respect to range 
of motion, shoulder pain, performance of activities of daily living, hypertonia, 
spasticity, motor control or shoulder subluxation.
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Introduction
Annually, 15 million people worldwide suffer a stroke.1 About 77–81% of stroke 
survivors show a motor deficit of the extremities.2 In almost 66% of patients with an 
initial paralysis, the affected arm remains inactive and immobilised due to a lack of 
return of motor function after six months.3,4 Over time, the central nervous system 
as well as muscle tissue of the arm adapt to this state of inactivity, often resulting 
in residual impairments such as hypertonia,5,6 spasticity7 or contractures.7-9 In turn, 
these secondary impairments are associated with hemiplegic shoulder pain10,11 
and restrictions in performance of activities of daily living.12,13
Several interventions improve arm function after stroke and prevent secondary 
impairments, eg, bilateral arm training14 or constraint-induced movement therapy.15 
However, these interventions are not suitable for people with severe motor deficits 
because they require ‘active’ residual arm motor capacity. For these people ‘passive’ 
interventions may be needed to prevent secondary impairments and optimise 
long-term handling and assistive use of the affected arm. It is also important to 
elicit muscle activity if at all possible, and to improve arm function. To prevent the 
loss of passive range of joint motion as a result of contracture of at-risk muscles 
in the shoulder (eg, internal rotators, adductors) and forearm (eg, pronators, wrist 
and finger flexors) in particular, the application of arm stretch positioning alongside 
regular physiotherapy was deemed important,16 especially because contractures 
are associated with shoulder pain.11,17,18  However, in general, passive stretch does 
not produce clinically important changes in joint range of motion, pain, spasticity, 
or activity limitations.19 One explanation for the lack of effect of passive stretch of 
the shoulder muscles could be the inadequate duration of stretch, with clinical 
trials using a dose of 20 or 30 minutes only.20 However, it is questionable whether 
stretch of the shoulder muscles for much more than 60 minutes per day during 
intensive rehabilitation programs is feasible.21
People with severe motor deficits after stroke have a higher risk of developing 
increased resistance to passive muscle stretch (hypertonia) and spasticity of the 
muscles responsible for an antigravity posture.5,8,22 These muscles are also at risk 
of developing contracture. As a result, the passive range of the hemiplegic shoulder 
(exteral rotation, flexion and abduction), elbow (extension), forearm (supination) 
and wrist (extension) can become restricted.
Stretching hypertonic muscles is difficult when they are not sufficiently relaxed. 
intervention, can not only be used to improve pain-free range of passive humeral 
lateral rotation,24 but also to reduce muscle resistance25  and glenohumeral 
subluxation.24,26 From these results we hypothesised that NMES of selected arm 
muscles opposite to muscles that are prone to the development of spasticity and 
contracture might facilitate static arm stretching both through reciprocal inhibition 
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(‘relaxation’) of antagonist muscles27-29 and the imposed (cyclic) stretch caused by 
motor amplitude NMES. Consequently, static arm stretch positioning combined 
with NMES could potentially result in larger improvements of arm passive range 
of motion and less (severe) shoulder pain compared to NMES or static stretching 
alone. From these hypotheses we developed the following research questions:
(1) Does eight weeks of combined static arm stretch positioning with simultaneous 
NMES prevent the loss of shoulder passive range of motion and the occurrence of 
shoulder pain more than sham stretch positioning with simultaneous sham NMES 
(ie, transcutaneous electrical stimulation, TENS) in the subacute phase of stroke? 
(2) Does the experimental intervention have any additional effects on timing and 
severity of shoulder pain, restrictions in daily basic arm activities, resistance to 




A multicentre, assessor-blinded, randomised controlled trial was conducted. After 
inclusion, participants were randomised in blocks of four (2:2 allocation ratio) in two 
strata (Fugl-Meyer Assessment arm score 0–11 points and 12–18 points) at each 
treatment centre. Opaque, sealed envelopes containing details of group allocation 
were prepared by the main co-ordinator (LDdJ) before trial commencement. After a 
local trial co-ordinator had determined eligibility and obtained a patient’s consent, 
the main co-ordinator was contacted by phone. He instructed an independent 
person to draw an envelope blindfolded and to communicate the result back to 
the local trial co-ordinator. The local trial co-ordinator then made arrangements 
for the baseline measurement after which the allocated intervention was initiated. 
Mid-treatment, end-treatment, and follow-up measurements took place at 4, 
8, and 20 weeks after baseline measurement by two independent assessors 
(physiotherapists), who were unaware of group allocation and not involved in the 
treatment of participants. To keep the assessors blinded, participants were reminded 
before each measurement not to reveal the nature of their treatment. Participants 
were considered to be unaware of group allocation because they were informed 
about the existence of two intervention groups but not about the study hypothesis. 
The participants’ and assessors’ beliefs regarding allocation were checked at 
the eight-week (ie, end of treatment) assessment using a three-point nominal 
scale (I suspect allocation to experimental/control group, I have no clue of group 
allocation). All investigators, staff, and participants were kept blinded with regard 
to the outcome measurements.
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Participants
Between August 2008 and September 2010, consecutive newly admitted patients
on the neurological units of three rehabilitation centres in the Netherlands 
(Beetsterzwaag, Doorn, and Zwolle) were approached for participation. Willing 
patients were initially screened by a physician for the following inclusion criteria: 
first-ever or recurrent stroke (except subarachnoid haemorrhages) between two and 
eight weeks poststroke; age > 18 years; paralysis or severe paresis of the affected 
arm scoring 1–3 on the recovery stages of Brunnstrom30; and no planned date 
of discharge within four weeks. Subsequently, a local trial co-ordinator excluded 
patients with: contraindications for electrical stimulation (eg, metal implants, 
cardiac pacemaker); pre-existing impairments of the affected arm (pre-existing 
contracture was not an exclusion criterion); severe cognitive deficits and/or severe 
language comprehension difficulties, defined as < 3/4 correct verbal responses and/
or < 3 correct visual graphic rating scale scores on the AbilityQ31; and moderate to 
good arm motor control (> 18 points on the Fugl-Meyer Assessment arm score).
Interventions
All participants received multidisciplinary stroke rehabilitation, ie, daily training 
in activities of daily living by rehabilitation nurses, occupational therapists, 
physiotherapists, and speech therapists. These interventions were not standardised, 
but generally administered in a way that was consistent with the recommendations 
of the Dutch stroke guidelines.32 Participants were requested to undergo the 
additional allocated treatment twice daily for 45 minutes on weekdays for 8 
weeks. Participants from the experimental group received arm stretch positioning 
(presented in Figures 1a and 1b) with simultaneous four-channel motor amplitude 
NMES. Participants from the control group received a sham stretch positioning 
procedure (presented in Figure 1c) with simultaneous sham conventional TENS 
with minimal sensory sensation by using a similar treatment protocol, electrical 
stimulator and electrode placement (but on the forearm only) as the experimental 
group. A detailed description of the experimental and control group procedures 
can be found in Appendix 1.
Treatment was planned to result in 60 hours of positioning and 51 hours of NMES/
TENS. All procedures were performed by the local trial coordinator or instructed 
nursing staff. Nursing staff monitored compliance to the intervention by logging 
each session on a record sheet, which was always kept in the vicinity of the 
participant’s bed. During the first eight weeks of the trial, prescription of pain 
and spasticity medication as well as content of physical and occupational therapy 
sessions for the arm were also monitored.
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Figure 1   Experimental and control arm muscle stretch positions and electrode placements. (a) The intervention 
used by experimental group participants with sufficient shoulder external rotation to achieve the position. (b) The 
intervention used by experimental group participants with insufficient shoulder external rotation. (c) The control (ie, 
sham) intervention .
Outcome measures
The primary outcome measures were passive range of arm motion and pain in 
the hemiplegic shoulder. All goniometric assessments were performed by two 
observers using a fluid-filled goniometer (MIE Medical Research Ltd, Leeds, UK)
Inter-observer reliability of this technique was high.33 The presence of shoulder 
pain was checked using the first (yes/no) question of the ShoulderQ.34 The 
secondary outcome measures were timing and severity of poststroke shoulder 
pain, performance of real-life passive and basic daily active arm activities, 
hypertonia and spasticity, arm motor control and shoulder subluxation. All 
measurements were carried out in the same fixed order by the same two trained 
assessors. Every effort was made to motivate participants to undergo all planned 
measurements even after withdrawal from the study Passive range of shoulder 
external rotation, flexion and abduction, elbow extesion, forearm supination, 
wrist extension with extended and flexed fingers were assessed because these 
movements often develop restrictions in range as a result of imposed immobility, 
with muscle contractures causing a typical flexion posture of the hemiplegic arm. 
The (entire) ShoulderQ was administered in participants who indicated that they 
had shoulder pain. This questionnaire assesses timing and severity of pain by 
means of eight verbal questions and three vertical visual graphic rating scales. We 
were primarily interested in the answer to the (verbal) question How severe is your 
shoulder pain overall? (1= mild, 2 = moderate, 3 = severe, 4 = extremely severe) 
a                                                           b                                                        c
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Figure 2   Design and flow of participants through the trial. aAll reasons for exclusion are listed where patients were 
ineligible for multiple reasons. b Including multiple sclerosis, Alzheimer’s disease, locked-in syndrome, recurrent stroke, 
and participation in another trial. NMES = neuromuscular electrical stimulation. c One participant from each group
dropped out after randomisation but before receiving any intervention. d Unrelated to stroke. e One participant missed 
the Week 4 assessment due to poor weather. f One participant missed the Week 8 assessment due to recurrent stroke 
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and TENS 90 min a 
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day, 5 days a week 
 




• shoulder pain (n = 2) 
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hospital
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• sham arm positioning 
and TENS 90 min a 
day, 5 days a week 
Lost to follow-up 
• death (n = 1) 
• increased shoulder 
pain (n = 1) 
Discontinued intervention 
• discharge (n = 1) 
 
Discontinued intervention 
• forearm pain (n = 1) 
• recurrent stroke        
(n = 2) 
• discharge (n = 1) 
 
Lost to follow-up 
• severe shoulder 
subluxation (n = 1) 
• did not attend (n = 3) 
Measured passive range of motion, shoulder pain, restrictions in performance of activities of daily life, 
hypertonia/spasticity, motor control and shoulder subluxation 
 
(n = 18)             Received prescribed intervention            (n = 17) 




• no intervention 
Experimental Group 
• no intervention 
 
Measured passive range of motion, shoulder pain, restrictions in performance of activities of daily life, 
hypertonia/spasticity, motor control and shoulder subluxation 
 
(n = 21)           Received prescribed intervention             (n = 21) 
(n = 23)                             Analysed                                (n = 21)
e
 
Measured passive range of motion, shoulder pain, restrictions in performance of activities of daily life, 
hypertonia/spasticity, motor control and shoulder subluxation 
 
(n = 24)                          Randomised                            (n = 24) 
(n = 23)                             Analysed
c
                              (n = 23) 
Measured passive range of motion, shoulder pain, restrictions in performance of activities of daily life, 
hypertonia/spasticity, motor control and shoulder subluxation 
 
(n = 17)                              Analysed                              (n = 22) 
Excluded after initial screening
a
 (n = 180) 
• no ischaemic/haemhorragic stroke (n = 9) 
• > 8 weeks post-stroke (n = 28) 
• Brunnstrom’s stage of recovery ! 4 (n = 169) 
• pre-existent arm impairments (n = 24) 
• planned date of discharge too soon (n = 64) 
• refused / unable to participate (n = 6) 
• otherb (n = 8) 
• unknown / missing data (n = 4) 
 
Excluded after inclusion testing (n = 32) 
• unable to fill out, read or understand the 
AbilityQ (n = 9) 
• Fugl-Meyer Assessment arm score  
>18 points (n = 14) 
• contraindications to electrical stimulation (n = 1) 




 Week 20     
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and pain severity measured at rest, on movement, and at night using the 10-cm 
vertical visual graphic rating scales. The ShoulderQ is sensitive34 and responsive 
to change in pain experience.31 Performance of basic functional activities of daily 
life involving the passive arm was assessed using the Leeds Adult/Arm Spasticity 
Impact Scale.35 Using this semi-structured interview, participants were asked to 
indicate whether they or their carer(s) experienced difficulty performing 12 different 
tasks involving the hemiplegic arm (cleaning the palm/elbow/armpits, cutting 
fingernails, putting the arm through a sleeve/in a glove, rolling over in bed, doing 
exercises, balancing while standing/walking, and holding objects). The scores on 
the separate items (1 point = no difficulty, 0 = difficulty or activity not yet performed) 
were summed, divided by the total number of items performed and multiplied 
by 100, resulting in a summary score (0 = severe disability, 100 = no disability). 
Hypertonia and spasticity of the shoulder internal rotators, elbow flexors, and 
long finger flexors were assessed using a detailed version36 of the Tardieu Scale.37 
The Tardieu Scale can differentiate spasticity from contracture38,39  and has fair 
to excellent test-retest reliability and inter-observer reliability.40 The mean angular 
velocity of the Tardieu Scale’s fast movement was standardised (see Appendix 
2). Muscle reaction quality scores ≥ 2 were considered to be clinically relevant 
hypertonia. Spasticity was deemed present if the angle of catch was present and 
occurred earlier in range than the maximal muscle length after slow stretching 
(ie, spasticity angle > 0 degs). Arm motor control was assessed using the 66-point 
arm section of the Fugl-Meyer Assessment.41,42 Shoulder inferior subluxation was 
diagnosed by palpation43 in finger breadths (< ½, < 1, ≥ 1, > 1½) and considered 
present if it was one category higher than on the nonaffected side. 
Data analysis
Sample size calculation was based on a reliably assessable change in passive 
shoulder external rotation range of motion of ≥ 17 degs.33 The clinically relevant 
difference between the experimental and control intervention was therefore set 
at a minimum of 20 degs. The standard deviation was considered to be 21.5 
degs.44 Alpha was set at 5% (two-sided), beta at 80%. Thus, the required 
number of participants in each group was 18. Anticipating a 10% drop-out rate 
and requiring 36 complete datasets, we aimed to recruit at least 20 participants 
per group. All participants minus two premature dropouts were analysed as 
randomised (intention-to-treat). Arm passive range of motion was analysed using a 
multilevel regression analysis. As main factors time (baseline, 4, 8, and 20 weeks), 
groupallocation (two groups) and time × group interaction were explored using 
the –2log-likelihood criterion for model fit, as well as random effects of intercept 
and slope. For completeness, this analysis was repeated using the data of the 
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participants including the two premature dropouts (n = 48) using the last observation 
carried forward approach. Nominal outcome measures (presence of hypertonia/
spasticity and subluxation) at eight weeks were analysed using a Chi-square test. 
Ordinal outcome measures (Fugl-Meyer Assessment, Leeds Adult/Arm Spasticity 
Impact Scale, ShoulderQ) were first analysed for time effects within subjects using 
the Friedman test. If differences over time (from baseline to follow-up) were found, 
these were further explored using the Wilcoxon signed-rank test with Bonferroni-
Hochberg correction.45 Between-group differences were analysed using a Mann-
Whitney U test only at 8 weeks to avoid multiple testing.
Results
Flow of participants through the trial
The flow of participants through the trial is presented in Figure 2. Forty-eight 
patients met all eligibility criteria. One participant from the experimental group (a 
68-year-old female with a right-sided ischaemic stroke who regretted participation) 
and one from the control group (a 62-year old male with a left-sided ischaemic 
stroke who was rehospitalised due to acute liver-and kidney failure) dropped out 
the day after baseline measurement and before receiving any intervention. These 
participants were not included in the analyses because their data were missing 
due to unavailability for further measurements. Of the 11 patients who were lost 
to follow-up or discontinued their prescribed intervention during the eight-week 
treatment period, four (36%) complained of pain. Baseline characteristics of the 46 
participants analysed are shown in Table 1. Twenty-two participants (51%, n = 43) 
had no clue as to which group they were allocated, but 17 participants (40%) were 
correct in their belief regarding allocation. The three participants who were lost to 
follow-up before eight weeks did not provide data about allocation beliefs. The two 
assessors had no clue regarding group allocation in 67% and 72% of the cases. 
They were correct in their belief regarding allocation in 9 (21%) and 4 (9%) of the 
participants, respectively.
Co-interventions and compliance with trial method
In the experimental group more participants were prescribed pain and spasticity 
medication, as presented in Table 2. They also received slightly more conventional
therapy for the arm and adhered less to the prescribed intervention protocol. Overall, 
compliance in the experimental group was 68% (stretch positioning) and 67% (NMES), 
compared to 78% (sham positioning) and 75% (TENS) in the control group. Non-
compliance was mainly caused by drop-out and early weekend leaves. All mentioned 
differences between the groups were not statistically significant.
4 4
63
Table 1   Baseline characteristics of participants and centres
Characteristic Exp(n = 23)
Con
(n = 23)
Age (yr), mean (SD) 56.6 (14.2) 58.4 (9.6)
Time post-stroke at baseline (days), mean (SD) 43.7 (13.3) 43.3 (15.5)
MMSEa: median (IQR) 27 (23 to 28.25) 28 (26 to 29.5)
Gender, n males (%) 15 (65) 12 (52)
Stroke type, n (%)
     ICVA 19 (83) 18 (78)
     HCVA 4 (17) 5 (22)
Affected hemisphere, n right (%) 12 (52) 8 (35)
Aphasia, n (%) 5 (22) 6 (26)
Initial FMA arm score, n (%)
     0-11 points 19 (83) 17 (74)
     12-18 points 4 (17) 6 (26)
Centres
     Participants treated, n (%)
          Beetsterzwaag 7 (30) 8 (35)
          Doorn 4 (17) 4 (17)
          Zwolle 12 (52) 11 (48)
Exp = experimental group, Con = control group, FMA = Fugl-Meyer Assessment armscore, HCVA = haemorragic
cerebrovascular accident, ICVA = ischaemic cerebrovascular accident, MMSE = Mini Mental State Examination.
a Not administered in subjects with aphasia.
Effect of intervention
All primary and secondary outcome measures are presented in Tables 3, 4 and 5.
Except for elbow extension and the control participants’ wrist extension with
extended fingers, both groups showed reductions in mean passive range of motion 
of all joints (Table 3). The multilevel regression analysis identified significant time 
effects for the three shoulder movements and for forearm supination. There was no 
significant group effect nor a significant time × group interaction. A random intercept 
model fitted the data best (–2log-likelihood criterion). At end-treatment, the mean 
between-group difference for passive shoulder external rotation was 13 degs (95% 
CI 1 to 24). At baseline, 37% of all participants (ie, 17/46) reported shoulder pain, as 
presented in Table 4. At eight weeks, this percentage was 52% (ie, 22/42) with a 
relative risk of shoulder pain in the experimental group of 1.44 (95% CI 0.80 to 2.62), 
but no significant difference between the groups (Chi-square = 1.53, p = 0.217). 
At follow-up 36% (ie, 13/39) of all participants had shoulder pain. At eight weeks, 
participants with shoulder pain showed no significant between-group differences 
in their responses to the verbal question as well as in the visual graphic rating scale 




















































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































   
   
   
   
   
   
   
   
   
   
   
   































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































Table 2    Mean (SD) or number of participants (%) for co-interventions and compliance to the intervention protocol during-
the eight-week intervention period and mean difference (MD) or percentage risk difference (RD) between groups, with 
95% confidence intervals (95% CI).
Outcome Groups






Prescription of pain medication, n (%) 16 (73)a 11 (48) RD 25% (–4% to 50%)
Prescription of spasticity medication, n (%) 5 (23)a 2 (9) RD 14% (–8% to 36%)
Upper limb occupational therapy (hr), mean (SD) 5 (4)a 4 (4)a MD 1 (–2 to 3)
Upper limb physiotherapy (hr), mean (SD) 3 (5) 2 (3)a MD 1 (–2 to 3)
Total of positioning (hr), mean (SD) 41 (17)a 47 (16) MD-6 (–15 to 4)
Total of electrical stimulation (hr), mean (SD) 34 (16)a 38 (14) MD-4 (–13 to 5)
Exp = experimental group, Con = control group. aData missing for one participant.
patterns which hindered within- and between-group comparisons of those with 
shoulder pain only. There were no significant between-group differences on the 
Leeds Adult/Arm Spasticity Impact Scale, the Modified Tardieu Scale, the Fugl-Meyer
Assessment arm score, and the subluxation scores at end-treatment, as presented 
in Table 5. It is of note that all participants with clinically relevant hypertonia also 
demonstrated a spasticity angle > 0 degs and that Tardieu Scale scores for the 
internal rotators could not be obtained in a large number of participants because 
they had very limited (< 70 degs) total shoulder external rotation range. The overall 
prevalence of subluxation decreased from baseline (61%) to follow-up (31%).
Discussion
To our knowledge this is the first study to analyse the effects of a daily arm stretch 
positioning procedure combined with simultaneous NMES in patients with a poor 
prognosis for functional recovery in the subacute phase after stroke. The eight-week 
high-intensity multimodal intervention did not result in any significant differences 
in arm passive range of motion (contractures), shoulder pain, basic arm activities, 
hypertonia/spasticity, arm motor control or shoulder subluxation compared to a 
control group receiving a similar amount of sham positioning combined with TENS 
in addition to conventional rehabilitation.
Previous attempts to maintain hemiplegic arm joint range of motion using static 
muscle stretching procedures could not prevent considerable loss of shoulder 
passive range of motion.21,44,46,47 Our participants showed similar reductions in 
mean passive range of motion across most arm joints. Overall, there were no 
significant differences in passive range of motion between the two groups. At 
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baseline (on average, six weeks post-stroke), 37% of the participants reported 
(shoulder) pain. During the intervention period, the prevalence increased to 52% 
and decreased to 36% three months later. These findings are in line with reports 
that post-stroke shoulder pain is common, affecting 22–64% of cases, particularly 
patients with poor arm function.11,13,48 Overall, pain severity also increased, 
particularly on movement and at night. This adverse effect was also noted in 
other trials.21,46 Although there were no significant between-group differences 
regarding shoulder pain, worrisome observations were that in the experimental 
group some participants reported that they considered the intervention to be very 
arduous, pain and spasticity medication were prescribed more frequently, and 
protocol compliance was lower. Combined with the finding that shoulder pain was 
more likely to occur in participants in the experimental group than in the control 
group (relative risk 1.44), these findings may indicate that for some participants the 
experimental procedure was not well tolerated.
During the eight weeks of intervention our participants showed increased Leeds 
Adult/Arm Spasticity Impact Scale sum scores and Fugl-Meyer Assessment arm 
motor scores, changes that were probably not clinically relevant and caused by 
a mix of spontaneous post-stroke recovery of function, learned capacity to use 
compensatory movement strategies of the nonaffected arm and/or increased 
involvement of the carer. Overall, the prevalence of elbow flexor hypertonia and 
spasticity jointly increased up to 55% at the end of the treatment period, roughly 
corresponding to three months post-stroke for our participants. These results 
are in concordance with previous work.5,6,22 The unexpected high prevalence 
of hypertonia and spasticity (62%) and a decreasing prevalence of shoulder 
subluxation (31%) at follow-up in our sample may be explained by the fact that 
patients with relatively poor arm motor control have a higher risk of developing 
hypertonia.5
Although we performed an intention-to-treat analysis (ie, using any available data 
from all randomised subjects), we did not use forward imputation of missing 
data representing a clinical variable (eg, shoulder passive range of motion) that 
is worsening over time,17 as this might increase the chance of a Type I error. 
However, for completeness, this stricter intention-to-treat analysis using the data 
of all randomised subjects (n = 48) was performed. This analysis was similar in 
outcome to the original analysis but revealed an additional time effect of wrist 
extension with flexed fingers. A per protocol analysis would also have resulted 
in similar results because no patients crossed over to the other group. We also 
refrained from performing a sensitivity analysis based on compliance because 
4 4
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meaningful conclusions could not be drawn from the resulting limited sample 
sizes. We furthermore acknowledge that the Leeds Adult/Arm Spasticity Impact 
Scale lacks psychometric evaluation and our method to standardise the Tardieu 
Scale’s stretch velocity (V3) using a metronome was not validated and tested 
for reliability. Therefore, our data regarding basic arm activities, hypertonia, and 
spasticity should be interpreted with caution. Finally, because overall compliance 
to both protocols was only about 70%, an underestimation of the treatment effect 
may also have occurred. Nevertheless, the combined administration of 43 hours 
of static stretching and 36 hours of NMES was more than administered during any 
previous trial.20
A recent study produced inconclusive evidence about the effectiveness of a 
combined intervention of electrical stimulation in conjunction with prolonged muscle 
stretch (using a splint) to treat and prevent wrist contracture.49 Similarly, our results 
also showed no added benefit of electrical stimulation during static stretching of 
the shoulder and arm. The results of these multimodal approaches to the problem 
of post-stroke arm contracture development are in line with the conclusion of a 
review19 that static stretch positioning procedures have little, if any, short or long 
term effects on muscle contracture (treatment effect ≤ 3 deg), pain, spasticity, or 
activity limitations. Although pooled data from studies investigating the effects 
of electrical stimulation suggested some treatment effects on functional motor 
ability26 and pain-free range of passive humeral lateral rotation in patients with 
residual arm motor capacity,24 we found no such results in our sample of patients 
without residual arm motor capacity. As the combined procedure did not result in 
any meaningful treatment effects, it suggests that application of muscle stretching 
or NMES alone as a monotherapeutic intervention will not have a clinically relevant 
impact in this subgroup of patients either.
Research to date suggests that it is not possible to control or overcome (the 
emergence of) contractures and hypertonia using the current static arm muscle 
stretching procedures. Similarly, NMES of the antagonists of the muscles prone 
to shortening does not seem to provide additional benefits either. We therefore 
argue that these techniques should be discontinued in the treatment of patients 
with a poor prognosis for functional recovery. In this subgroup of patients it is 
becoming an increasingly difficult challenge to find effective treatments that can 
prevent the development of the most common residual impairments such as 
contractures, hypertonia, and spasticity and its associated secondary problems 
such as shoulder pain and restrictions in performance of daily life activities. Further 
research is required to investigate what renders these interventions ineffective. The 
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efficacy of other approaches, such as transcranial magnetic stimulation, NMES of 
the muscles prone to shortening,50 or other combinations of techniques, could 
also be investigated.
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Details of intervention method
Experimental group
The aim of the electrical stimulation was to enhance the mobilising effect of the 
static positioning procedure, i.e. to mobilise the wrist to pure wrist (≤ 20 degrees) 
and finger extension (stretching the wrist and finger flexors) and to mobilise the 
shoulder to external rotation, horizontal extension and slight abduction (stretching 
the internal rotators, flexors and adductors). First, electrodes were placed over 
the motor point of the extensor digitorum communis muscle and the dorsal 
surface of the distal forearm. Two other electrodes were placed over the dorsal 
surface (pars posterior) of the deltoid muscle and over the infraspinatus/teres 
minor muscle(s). The electrical stimulator (STIWELL-med4, Otto Bock HealthCare, 
Germany) was programmed to deliver a symmetric bi-phasic wave pattern of 35 
Hz and a pulse width of 300µs. Stimulation on and off time was 8 seconds with a 
3 second ramp-up and ramp-down. For skin adaptation purposes the stimulation 
time was gradually increased from 10 to 45 minutes per session (with increments 
of 5 minutes every other day) during the first 13 days. Amplitudes never exceeded 
the individual’s comfort level and skin checks were performed after every session. 
After electrode placement, the arm was carefully positioned in maximally available 
pain-free shoulder abduction and external rotation while avoiding impingement of 
the rotator cuff muscles. Because of individual differences in PROM, the position 
of the arm varied (Figure 1a and 1b). To keep the fingers and wrist in a neutral 
position, the  forearm supinated and to pull the shoulder into external rotation, a 
sandbag (± 0.5 kg) was placed on the volar surface of the hand. Participants were 
instructed not to change the position of the arm or trunk during treatment.
Control Group
The basic stimulation (80Hz, pulse width 150µs) was just above the participants’ 
sensation threshold, giving no muscle contraction but a tingling sensation at the 
most. Subsequently, the affected arm was positioned in shoulder internal rotation 
and ≤ 30 degrees of abduction (Figure 1c).
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Appendix 2
Tardieu Scale1 terminology and measurement procedure
Terminology:2
Velocity to stretch (V):
V1: As slow as possible.
V2: Speed of the limb segment falling under gravity.
V3: As fast as possible (faster than the rate of the natural drop of the limb
 under gravity).
Only V2 and V3 are used to rate spasticity
For each muscle group, reaction to stretch was rated at the specified stretch 
velocity with two parameters X and R.
Quality of muscle reaction (X):
0: No resistance throughout the course of the passive movement.
1: Slight resistance throughout the course of the passive movement, with 
 no clear catch at a precise angle.
2: Clear catch at a precise angle, interrupting the passive movement,
 followed by release.
3: Fatigable clonus (< 10 seconds when maintaining pressure) occurring at
 a precise angle.
4: Infatigable clonus (> 10 seconds when maintaining pressure) occurring at
 a precise angle.
Angle of muscle reaction (R):
R1: angle of ‘catch’, resulting from overactive stretch reflex.
R2: angle of the muscle length at rest.
The difference between R2 and R1 is the spasticity angle.
Measurement procedure
First, moving “as slow as possible” (V1) the total passive range of motion (PROMmax) 
of the actual joint was determined, including the muscle length at rest (R2). The 
standardized mean angular velocity (ω) of the fast movement (V3) was 300º/s3 
using a metronome to convert this velocity into an audible signal for the observers. 
Because each subject has a different PROMmax, the individual movement frequency 
(in beats per minute) had to be calculated (movement frequency = (ω / PROMmax) 
× 60). Participants with < 70º total shoulder joint rotation range (≥ 249 bpm on the 
metronome) were not assessed because of the imminent risk of injury at higher 
movements speeds. Joint ranges were clustered in groups of five degrees and 
corresponding beats per minute were rounded to their middle value (e.g. 70º-75º 
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at 257-240 bpm = 249 bpm). If applicable, one observer moved the joint through 
range (starting the movement on one click and ending it on the next) and rated 
the quality of the muscle reaction to stretch (X). The other observer assessed the 
‘angle of catch’ (R1) if it occurred. Grading was performed in a constant position of 
the body for the given joint. Other joints were kept in the same position throughout 
the test and between tests.
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To assess whether our measurement protocol using two raters simultaneously 
yielded reliable passive range of motion measurements of the hemiplegic arm.
Additionally, motion ranges were correlated to several factors to examine the
concurrent validity of these measurements.
Method
Two raters simultaneously assessed five arm motions at baseline, after five and ten 
weeks in respectively 18, 13 and 12 stroke patients. One tester made the passive 
movement and the other read the hydrogoniometer. Raters then switched roles.
Results
Intraclass correlation coefficients (ICCs) revealed high agreement between the
raters with ICCs ranging between 0.84 and 0.99. Standard errors of measurement 
and smallest detectable differences were large for shoulder abduction. Significant 
correlations were found between shoulder external rotation and flexion. All arm 
motions correlated negatively to pain at the end range of these motions. Shoulder 
external rotation and flexion were significantly correlated to the time poststroke. 
Concurrent validity with Ashworth Scale, Fugl-Meyer Assessment and Barthel
Index was limited.
Conclusions
The current measurement protocol yielded high reliability indices and seems
useful for further use. However, standard error of measurement and smallest
detectable difference for shoulder abduction were high, implying the neccesity to 
include a large sample size in future studies. Correlations revealed that restricted 
range of arm motions relate to the time poststroke and coincide with pain.
Keywords




Limitations in functions and activities of the hemiplegic arm are well known 
phenomena for those involved in the rehabilitation of stroke patients. Despite the 
fact that hemiplegic shoulder pain receives extensive attention in the literature, 
as expressed by a large number of recent articles and reviews,(eg. 1-3) it seems 
clear that it is still a long way before the most optimal combination of treatment 
modalities is found.
One of the most commonly used outcome measures in upper limb rehabilitation 
are active and passive range of motion (ROM), using (several types of) goniometers. 
Overall conclusions from the available reports indicate that range ofmotion 
measurements in healthy subjects and in patients with (most) orthopaedic 
conditions in the shoulder and elbow joint can be highly reliable, both within 
testers and slightly less between testers if some specific conditions are met.4-8 
Less, however, is known about the reliability of the measurements in neurological 
conditions such as stroke. Especially information concerning passive range of 
motion (PROM) measurements of the hemiplegic limb is scarce. This may have 
to do with the fact that it is difficult to assess range of motion of a limb that 
is more or less paralysed and in some cases resists passive movement as a 
consequence of spasticity and contractures. In addition to these problems, many 
stroke patients suffer from hemiplegic shoulder pain, a condition closely related 
to restricted range of motion.9,10 Using only one rater during PROM measurements 
under these conditions might introduce serious measurement errors, since it is 
difficult to handle the hemiplegic limb and goniometer and reading the score all 
simultaneously. 
Despite the presumption that aforementioned factors may limit a reliable 
assessment, reliability of PROM measurements in stroke patients was shown to 
be good for the shoulder joint with respect to lateral rotation.11 However, when it 
comes to measurements of motions other than shoulder external rotation or the 
assessment of the elbow and forearm joints, information is lacking.
As part of a randomized clinical trial into the effectiveness of a contracture 
preventive positioning procedure for the involved upper limb in stroke patients12 
we explored the interrater reliability of our PROM measurements. This study 
addressed the question whether PROM measurements were reliable when using a 
standardised measurement protocol. Since previous studies revealed relationships 
between passive joint range of motion and both pain and time poststroke, we 
additionally explored whether the baseline range of motion measurements had 
mutual correlations or correlated with pain scores, the time since onset of the 
stroke, resistance to passive stretch (‘spasticity’) as reflected by Ashworth Scale 
grades, the ability to make selective arm movements using the arm section of 
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the Fugl-Meyer Assessment and performance of activities of daily life (ADL) as 
reflected by the Barthel Index. Correlating these measures might be helpful in 




Subjects  were  selected from three rehabilitation centres in the Netherlands 
(Apeldoorn, Doorn and Zwolle). All stroke patients admitted between March 2003 
(one centre participated as from January 2004) and January 2005, were initially 
screened by a physician. Subjects had to meet the following inclusion criteria: (1) 
First ever stroke as defined by the World Health Organization13 and maximally 12 
weeks poststroke; (2) a medial cerebral artery stroke, established by means of 
CT/MRI; (3) no premorbid impairments of the affected upper limb; (4) no severe 
shoulder pain during passive arm motions as subjectively judged by the physician; 
(5) no use of antispasticity drugs; (6) no use of pain reducing drugs except 
for Paracetamol, (7) no planned date of discharge and (8) able to give written 
informed consent. Subjects with fair to good involved upper limb recovery (as 
defined by Brunnstrom’s stages of recovery 4, 5 or 614 as judged by the physician) 
were excluded. Patients who met the inclusion criteria were then referred to a 
physiotherapist, who administered tests to exclude patients with (9) severe neglect 
(a difference of more than three O’s on the letter cancellation test),15 severe loss 
of position sense (scores 2 and 3 on the Thumb Finding Test16-18) and cognitive 
impairment scoring lower than 23 points on the Mini Mental State Examination.19-21 
Subjects with aphasia who could not answer the questions of the Mini Mental State 
Examination were tested by means of the language comprehension sub-items 
of the Akense Afasie Test22 (minimum 67 points). Finally, patients who were able 
to prevent contracture by producing voluntary movement, having a Fugl-Meyer 
Assessment arm score23 of more than 18 points on the subscales for shoulder- 
and elbow motions, were excluded. The study All subjects gave written informed 
consent prior to participation.
Raters
Two raters, both physiotherapists, had 7 and 4 years of experience, respectively, 
with the treatment of stroke patients. Before the trial, raters received and studied 
a detailed, unpublished manual of a measurement procedure written for the sole 
purpose of this study. Subsequently, both raters received a standardised pre-trial 
training in administering the PROM measurements and practiced it on three stroke 
patients. Raters had no pre-trial experience using the hydrogoniometer and were 
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not involved in the design of the study or the treatment of the patients during the 
main trial.
Measurement procedure for PROM measurements and pain scores
All PROM measurements were performed using a masked fluid-filled (hydro)
goniometer (MIE Medical Research Ltd., Leeds, U.K.). A hydrogoniometer was 
found to be a reliable tool in quantifying ROM,11,24,25 probably due to the fact that 
the starting position of this type of goniometer can be consistently identified and 
repeated since gravity does not change.26 To ensure standardization of the PROM 
testing procedures the raters were trained beforehand,6,27 shoulder abduction 
was applied during several shoulder motions,5,11,27 and the two raters worked in 
pairs; one rater performed the passive motion and the other aligned and read the 
hydrogoniometer.28 The measurement protocol furthermore entailed the following 
procedures and rules: Before the actual measurement, each joint-motion was 
performed through the full range as a connective tissue ‘warm-up’. The movement 
speed of each measurement was at least 2 sec for the entire available range in 
order to make sure no stretch reflex (‘spasticity’) was elicited. Both raters were 
instructed to check for and prevent compensatory movements of the subject’s 
head or trunk that could influence the actual measurement.
The measurements of PROM of five arm motions were carried out as follows: the 
first rater carried out the ‘warming up’ and the actual passive movement. The 
second rater measured the maximum range with the hydrogoniometer. The value 
representing the lowest point of the column of fluid was noted with an accuracy 
to 1 degree. The second rater asked the subjects to report pain at the end feel 
of each passive motion (0 = no pain, 1 = pain). The second rater was instructed 
not to look at the hydrogoniometer while performing the motion despite the fact 
that the backside of the hydrogoniometer was opaque, and not to look at the rater 
while noting the score on the scoresheet. Then, the raters changed roles and the 
procedure was repeated only checking for, but not scoring pain. Measurement 
sequence was as follows: shoulder flexion, shoulder external rotation and elbow 
extension in supine, followed by shoulder abduction and forearm supination in 
sitting on an adjustable massage table with the back supported. The same two 
raters, who carried out all the measurements in the same fixed order, were blinded 
to each other’s results by using separate score sheets and were furthermore 
instructed not to discuss or mention the values found.
Statistical Analyses
Interrater reliability of the PROM measurements was calculated by means of
intraclass correlation coefficients (3,1) on data produced from a two-way analysis
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of variance (ANOVA)29 with consistency mode. The reason for choosing this type of 
intraclass correlation coefficient (ICC) was that the testing was only to be performed 
by two and the same raters for the purposes of assessing the reliability of the 
measurements for the main trial. Because an ICC alone gives no indication of the 
magnitude of disagreement between the raters, standard error of measurement 
(SEM) was calculated additionaly using the formula sd × √ (1-r). The smallest 
detectable difference (SDD) was calculated using the formula 1.96 × √2 × SEM. To 
prevent dependency in the data, the ICC-values were calculated for three different 
datasets, representing the three different evaluation moments of the main trial 
(baseline-, five and ten week measurements). Due to subject dropout from the main 
trial (as a result of illness, the administration of botulinum toxin/pain medication or 
discharge) and the absence of one of the raters, ICCs for respectively 18, 13 and 12 
subjects could be calculated. Mutual PROM correlations and correlations between 
motion range and the onset of stroke were calculated by means of the Pearson 
correlation coefficient. Correlations between the ratio-level PROM scores and the 
dichotomous pain score would require a point-biserial correlation coefficient. Since 
this correlation is equivalent to computing the Pearson correlation and is interpreted 
similarly, correlations between the different arm motions and painscores at the end 
range of these motions, Ashworth Scale gradings, Fugl-Meyer Assessment scores 
and Barthel Index scores were all calculated by means of the Spearman correlation 
coefficient. Correlation coefficients were calculated using baseline data only. All 
statistical procedures were carried out using SPSS for Windows (version 10.0.5).
Results
The included ten men and nine women had a mean (±SD) age of 54 (±10) years and 
were 39 (±12) days poststroke during the first evaluation. Most subjects suffered an 
ischaemic stroke (n = 14) and the side of hemiparesis was divided nearly equally 
over all subjects. The median score of the upper-extremity section of the Fugl-
Meyer Assessment was 10 out of a maximum of 66 points, implying that the 
participating subjects had very poor recovery of active arm movement capability. 
The subjects’ baseline PROM for shoulder external rotation ranged between 15 and 
94 degrees, shoulder flexion between 87 and 180 degrees, shoulder abduction 
between 65 and 104 degrees, elbow extension between 72 and 116 degrees and 
forearm supination between 25 and 99 degrees. Tables IA, IB and IC present the 
different values of the evaluations for the 18, 13 and 12 subjects at baseline, after 
five- and ten weeks, respectively. Overall the ICCs ranged between 0.78 and 0.99. 
The smallest detectable difference varied between 6 and 19 degrees of which the 
shoulder abduction measurements never reached values lower than 11 degrees. 
Table II shows that, in addition to a high positive correlation between the range of 
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Table I (A-C)   Intraclass correlation coefficients (ICCs; 95% confidence interval, 95% CI), standard error of measurement 
(SEM) and smallest detectable difference (SDD)  of passive range of motion (PROM) measurements between the two 
raters at (A) baseline, (B) five and (C) ten weeks.
Variable ICC 95% CI SEM SDD
   At baseline (n = 18)
Shoulder external rotation 0.94 0.85-0.98 3.05 8.45º
Shoulder flexion 0.98 0.95-0.99 3.60 9.98º
Shoulder abduction 0.84 0.62-0.94 4.32 11.97º
Elbow extension 0.78 0.49-0.91 4.86 13.47º
Forearm supination 0.94 0.85-0.98 4.42 12.25º
    At five weeks (n = 13)
Shoulder external rotation 0.97 0.91-0.99 3.53 9.78º
Shoulder flexion 0.99 0.97-0.99 3.00 8.31º
Shoulder abduction 0.87 0.64-0.96 5.94 16.46º
Elbow extension 0.94 0.81-0.98 2.59 7.18º
Forearm supination 0.95 0.84-0.98 4.18 11.58º
    At ten weeks (n = 12)
Shoulder external rotation 0.99 0.97-0.99 2.42 6.71º
Shoulder flexion 0.98 0.94-0.99 4.56 12.64º
Shoulder abduction 0.84 0.54-0.95 6.54 18.13º
Elbow extension 0.97 0.91-0.99 2.32 6.43º
Forearm supination 0.98 0.92-0.99 3.02 8.37º
SDD in degrees (º).
shoulder external rotation and shoulder flexion (r = 0.731, p = 0.01), all motions 
were negatively correlated to pain at the end of that particular motion. Shoulder 
abduction and forearm supination however were only moderately correlated to 
pain at the end range of motion (r = 0.456 and 0.459, p = 0.05). Shoulder flexion 
was furthermore negatively correlated to pain at the end of the four other motions 
and shoulder external rotation to pain at the end range of shoulder flexion and 
elbow extension. The passive range of shoulder external rotation and flexion were 
correlated to the time poststroke, albeit only at the five-percent significance level 
for the shoulder flexion. Furthermore, shoulder flexion was moderately correlated 
to the ability to make selective movements of the hemiplegic arm as assessed 
by the Fugl-Meyer Assessment and elbow extension was highly correlated to the 






Table 2   Correlations between hemiplegic arm passive range of motion (PROM) and pain at the end range of
motion, time since onset of stroke, resistance to passive stretch of the elbow flexors (Ashworth Scale), the ability to 















Shoulder flexion    0.731**
Shoulder abduction  0.056  0.356
Elbow extension  0.391  0.380  0.117
Forearm supination  0.306  0.355 -0.064  0.005
Pain
Shoulder external rotation -0.618** -0.459* -0.419 -0.329 -0.339
Shoulder flexion -0.655** -0.622** -0.044 -0.055 -0.219
Shoulder abduction -0.372 -0.559* -0.456* -0.124 -0.104
Elbow extension -0.478* -0.628** -0.060 -0.688** -0.010
Forearm supination -0.438 -0.598** -0.150 -0.060 -0.459*
Time poststroke -0.595** -0.483* -0.280  0.188 -0.454
Ashworth Scale  0.098  0.041  0.296 -0.207  0.157
Fugl-Meyer Assessment  0.174  0.467* -0.108  0.336  0.033
Barthel Index  0.151  0.143 -0.158  0.592**  0.063
*Correlation significant at the 0.05 level (2-tailed);
**correlation significant at the 0.01 level (2-tailed).
Discussion
The aim of this study was to investigate whether a standardized range of motion 
measurement protocol, using two raters simultaneously, would yield reliable 
measurements for five different passive motions of the hemiplegic arm. When 
classifying the ICC values as suggested by Portney and Watkins30 (≥ 0.75 high 
reliability, 0.40-0.75 moderate reliability, ≤ 0.40 poor reliability) the conclusion 
is justified that the overall interrater reliability of our measurement protocol was 
high. Standard error of measurement however varied between the three different 
evaluations, but was high for shoulder abduction on all occasions. The use of 
small sample sizes probably contributed to these high indices. Furthermore, 
passive shoulder external rotation and flexion were highly correlated. All five arm 
motions were correlated to pain at the end range of these motions. Shoulder 
external rotation and flexion were correlated to pain at the end range of nearly 
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all other motions and were also significantly correlated to the time post stroke. 
Although shoulder flexion was moderately and negatively correlated to the Fugl-
Meyer Assessment and elbow extension was highly correlated with the Barthel 
Index, concurrent validity of these measures with range of motion measurements 
seemed limited.
Comparison of our results with other studies on interrater reliability of PROM of 
the arm5,8,31-35 is hampered by differences in measurement protocols, including 
different goniometers, subjects, positions and observers. Our testing procedure 
mostly resembled the procedure used by Andrews and Bohannon,11 who found 
an interrater ICC of 0.96 for shoulder lateral rotation on the paretic side using 
25 stroke patients. During our three different evaluations of respectively 18, 13 
and 12 subjects we found comparable ICCs of 0.94, 0.97 and 0.99. This finding 
suggests that using two raters simultaneously instead of one does not result in 
more reliable measurements when assessing shoulder external rotation. However, 
we also assessed passive shoulder abduction and flexion. Especially these two 
movements could be difficult to measure by just one rater as the hemiplegic 
limb and goniometer have to be handled and read at the same time. Despite 
our hypothesis that two pairs of hands would yield more reliable measurements, 
shoulder abduction assessments clearly revealed lower ICCs than the other 
motions (maximum .87), although these values can still be considered high. 
Clearly, using two raters did not induce higher reliability indices on all occassions. 
In addition, from a rehabilitation practitioner’s point of view, it can be argued that 
using two pairs of hands is not always feasible when assessing range of motion. 
Nevertheless, our measurement protocol can still be useful for other motions than 
shoulder external rotation and for scientific purposes using stroke patients. 
One other major limitation of this study is the use of small sample sizes during the 
three different evaluations. Small sample sizes will yield an imprecise estimate of 
the reliability coefficients which is indicated by an excessively wide confidence 
interval.36 As a consequence, standard error of measurement increases. Standard 
errors of measurement found by MacDermid et al.5 indicated that differences of 
approximately 5-7 degrees could be attributable to measurement error within 
raters and somewhat greater between raters. Our standard errors of measurement 
varied between 2 and 7 degrees, confirming this range for stroke subjects. 
The smallest detectable difference (SDD) is another important index that may 
give therapists or scientists information as to whether a difference measured is 
due to random measurement error or actually represents a true change in the 
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patients PROM. Values generated during this trial showed that the SDD for the 
five different arm motions during the three different evaluations ranged between 6 
and 19 degrees. The minimum difference of, e.g., shoulder external rotation that 
needs to be exceeded to be reasonably certain that a real change has occurred 
was found to be 10 degrees. Applied to the other motions, the differences for 
shoulder flexion and forearm supination would have to be 13 degrees, 14 degrees 
for elbow extension and 19 degrees for shoulder abduction. These rather large 
SDD’s are probably caused by the use of the small sample sizes during the three 
different evaluations. The variation of smallest detectable differences between 
the five motions may reflect the number of degrees of freedom of the different 
joint motions; the more degrees of freedom, the harder they are to control. 
Compensatory movements of the trunk during shoulder abduction may therefore 
have contributed to larger measurement errors, and hence lower ICCs. On the 
other hand, the findings were replicated during three consecutive evaluations, 
which seem to support the robustness of the findings. Nevertheless, the SEM and 
SDD results imply the necessity to include a large sample size in future studies. 
Of all five motions tested, shoulder external rotation and flexion were most highly 
correlated (.731, p = 0.01). Restrictions of shoulder external rotation usually coincide 
with a decrease of glenohumeral flexion since elevation in all planes anterior to to 
the scapular plane require external axial rotation of the humerus.37 Contracture 
of shoulder connective tissue or hypertonus of shoulder muscles may have 
enhanced this relationship. Baseline data revealed that of all participating subjects 
the passive range of external rotation was restricted for approximately 50% and 
flexion for approximately 25% of the normal range (data published elsewhere12). 
The highly significant correlation combined with this 2:1 ratio could be used to 
clinically estimate the decrease of shoulder flexion on the basis of knowledge of 
the shoulder external rotation range of motion. However, this ratio needs future 
verification.
Each range of motion was significantly and negatively correlated with pain at the 
end range of that same particular motion. This is more or less in concordance 
with previous work,9,10,38-40 although the methods of assessment of PROM and 
pain varied between these different studies. In addition, shoulder flexion and (to a 
lesser extent) external rotation were correlated to pain at the end range of nearly 
all other motions.
This ‘passive-motion-range-and-pain’ relationship, found in this and previous 
studies, once again shows that it is highly likely that one month post stroke 
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hemiplegic arm motions are restricted and painful. Similar to the findings of Andrews 
and Bohannon11 and Bohannon et al.,9 we found a positive relationship between 
shoulder external rotation on the paretic side and time since onset of stroke. In our 
study, this relationship was also moderately high for shoulder flexion (r = 0.483, 
p = 0.05). These relationships make it clear that the amount of time passed since 
the onset of a stroke closely relates to a decrease in hemiplegic arm range of 
motion. This may be caused by gradual contracture formation. Decreased PROM 
of the arm joints, in turn, is related to pain at the end range of these motions, 
although, the cause of the developing pain is thought to be multifactorial.2 
The passive shoulder flexion correlated moderately to the Fugl-Meyer Assessment 
scores. Since reductions in arm motion ranges affect this motor score, this finding 
was not surprising. It was surprising, however, to find that the correlation was only 
significant for shoulder flexion, a result which is difficult to interpret. Finally, passive 
elbow extension was correlated to independence in ADL, which is also difficult to 
explain since the Barthel Index only assesses functional activities and does not 
take arm motion ranges into account.
Although we established the reliability of measurements using two independent 
raters only, our measurement protocol seems to be of use for other raters under 
comparable circumstances. Trials with larger samples of stroke subjects should 
reveal if using two raters simultaneously yields higher reliability indices than only 
a single rater for arm movements other than shoulder external rotation. Given 
the low correlations of the range of motion measurements with the Ashworth 
Scale, Fugl-Meyer Assessment and the Barthel Index, the concurrent validity of 
the range of motion measurements seems to be limited. The correlation with the 
time poststroke indicates the importance of early intervention strategies aimed at 
preventing loss of range of motion in the hemiplegic arm.
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Goniometric measurements of hemiplegic arm joints must be reliable to draw proper 
clinical and scientific conclusions. Previous reliability studies were cross-sectional 
and  based on small samples. Knowledge about the contributions of sources of 
variation to these measurement results is lacking. 
Objective
The aims of this study were to determine interobserver reliability of measurements 
of passive range of motion (PROM) over time, explore sources of variation associated 
with these measurement results, and generate smallest detectable differences for 
clinical decision making.
Design
This investigation was a measurement-focused study with a longitudinal design, 
nested within a two-arm randomized controlled trial.
Methods
Two trained physical therapists assessed seven arm movements at baseline and 
after 4, 8, and 20 weeks weeks in 48 people with subacute stroke patients using a 
standardized protocol. One physical therapist performed the passive movement, 
and the other read the hydrogoniometer. The therapists then switched roles. The 
relative contributions of several sources of variation to error variance was explored 
with analysis of variance.
Results
Interobserver reliability coefficients ranged from .89 to .97. The PROM measurements 
were influenced by error variance ranging from 31% to 50%. The participant x time 
interaction made the largest contribution to error variance, ranging from 59% to 
81%. Smallest detectable differences were 6 to 22 degrees and were largest for 
shoulder movements.
Limitations
Verification of shoulder pain and hypertonia as sources of error variance led to 
a substantial number of unstable variance components, necessitating a simpler 
analysis.
Conclusions
The assessment of PROM with a standardized protocol, a hydrogoniometer, 
and two trained physical therapists yielded high interobserver reliability indexes 
for all arm movements. Error variance made a large contribution to the variation in 
measurement results. The resulting smallest detectable differences can be used to 
interpret future hemiplegic arm PROM measurements with more confidence.
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Introduction
Of the 15 million people who have a stroke each year worldwide, between 77% 
and 81% of the survivors have a motor deficit in the extremities.1 The affected 
arm remains without function in almost 66% of survivors,2,3 rendering it inactive 
and immobilized. In recent years, several interventions believed to improve 
motorrecovery or limit development of secondary impairments in the paretic or 
paralyzed arm after stroke have been evaluated.(eg. 4,5) 
To assess the arm function of patients with stroke during rehabilitation and in 
clinical research, physical therapists regularly assess passive range of motion 
(PROM) of joints by means of goniometry. In particular, the degree of passive 
shoulder external rotation and abduction and wrist extension are commonly 
used as outcome measures to evaluate the effects of interventions.6-13 Reliable 
measurement of PROM is therefore an important prerequisite for the interpretation 
of study results. The reliability of arm range-of-motion measurements is good in 
people who are healthy14,15 and in patients with orthopedic conditions,16,17 but 
these findings cannot be generalized to patients with stroke because stroke-
specific impairments may influence reliability. Over time, many patients develop 
contractures10,18 and hypertonia,19,20 especially in shoulder internal rotators and 
wrist flexors. Many patients also develop shoulder pain, a condition strongly 
associated with restricted range of motion.21,22 The aforementioned factors may 
hinder the therapist’s attempts to move the hemiplegic arm, hence increasing 
the chance of making measurement errors. Such errors also may be increased 
if PROM measurements are obtained by only one therapist because it is difficult 
to handle a paralyzed arm and the goniometer and read the measurement 
simultaneously. Goniometric measurements of arm joints reflect both the true 
range of a joint and measurement errors caused by different sources of variation. 
Identifying and quantifying these sources are important for finding strategies 
to reduce their influence on outcomes.23 In addition, to ensure accurate clinical 
interpretation of joint PROM measurements and changes in these measurements 
over time during poststroke rehabilitation or research, PROM measurements 
should be studied in the context of these sources of variation. In previous studies 
of arm PROM reliability in patients with stroke, sample sizes have not exceeded 18 
people.24,25 To our knowledge, research into factors that may influence hemiplegic 
arm PROM measurements is also lacking. During a randomized controlled trial,26 
two physical therapists (hereafter referred to as ‘observers’) assessed arm joint 
PROM in 48 people on four occasions over 20 weeks. This design presented us 
with the opportunity to explore interobserver reliability, analyze the contributions of 
sources of variation to the measurement results, and calculate smallest detectable 
differences (SDDs). We chose to use two observers because we hypothesized that 
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doing so would result in fewer measurement errors than using one observer only 
and because a similar measurement procedure previously yielded high reliability 
indices.25
Method
As part of a randomized clinical trial investigating an arm intervention for people 
with subacute stroke and poor arm recovery, we used an existing measurement 
protocol that was specifically designed for measuring the PROM of seven arm 
movements. All participants gave written informed consent before participation.
Participants
Participants were recruited from three Dutch rehabilitation centers between August 
2008 and September 2010. All admitted participants were initially screened by a 
physician to check the following inclusion criteria: first-ever stroke or recurrent 
stroke (except for  subarachnoid haemorrhages) between two and eight weeks 
after the initial stroke, age of 18 years or older, paralysis or severe paresis of 
the involved upper limb (Brunnstrom stage of recovery of < 4,27 as judged by 
the physician) and no planned date of discharge within four weeks. Participants 
meeting these criteria were referred to a research physical therapist, who 
excluded those with any contraindications for electrical stimulation, preexisting 
impairments of the affected arm (eg, frozen shoulder), severe cognitive deficits or 
severe language comprehension difficulties or both (<3/4 correct verbal responses 
and/or <3 correct visual analog scale scores on the AbilityQ28), and moderate to 
good arm motor control (scores of >18/66 on the Fugl-Meyer Assessment arm 
section29).After eligibility was confirmed, half of the participants were randomized to 
anexperimental group, and half were randomized to a sham intervention group.26
Observers
The two observers (both senior physical therapists) had 14 and 27 years of 
experience, respectively, across a wide range of diagnoses, including stroke. 
Before the trial, the observers were trained in obtaining the measurements using 
a detailed measurement protocol (the protocol, in Dutch, is available from the 
first author). They pretested the protocol on three participants with stroke. The 
observers had no pretrial experience with a hydrogoniometer and were not involved 
in the design of the study or the treatment of the participants.
PROM Measurement Procedure
All PROM measurements were obtained with a masked fluid-filled hydrogoniometer 
(MIE Medical Research Ltd, Leeds, United Kingdom). The measurement 
6 6
93
procedure was similar to the one described in detail in an earlier publication25 
but was expanded to include wrist extension assessments. Each participant was 
independently assessed by the two observers at baseline and after 4, 8, and 
20 weeks. Each time, one observer carried out the passive movement, and the 
other observer read the goniometer. The observers then switched roles. They 
were unaware of each other’s results because they used separate score sheets 
and were instructed not to discuss or mention the values found. The measurement 
sequence was as follows: shoulder external rotation, shoulder flexion, and elbow 
extension with the participant in the supine position and then shoulder abduction, 
forearm supination, and wrist extension with and without finger flexion while the 
participant sat on an adjustable plinth with the back supported. The observers 
carried out all measurements in the same fixed order.
Data Analysis
The variance components and their two-way interactions were calculated for the 
measurement conditions of participants (n = 48), time (four assessments over time), 
and observers (n = 2) by analysis of variance (type III sum of squares). Initially, the 
allocated intervention was also included in the calculation of variance components. 
However, for shoulder PROM, the variance component for intervention could 
not be estimated, indicating a redundancy. We therefore decided not to include 
intervention in the calculations of variance components. In case of missing data 
(eg, because of participant dropout or vacation taken by one of the observers), 
only data from participants who were assessed by both observers were used 
in the analysis. Error variance was calculated as the sum of all variances minus 
participant variance. The relative contributions of the sources of variation to this 
error variance were expressed as percentages. The agreement between the 
PROM ratings of the observers was calculated (see Streiner  and Norman23   [p159] for 
formulas) by means of interobserver reliability coefficients and accompanying 95% 
confidence intervals (CIs). Because the reliability coefficient alone did not indicate 
the magnitude of disagreement between the observers, the standard errors of 
measurement (SEMs) [SDx√(1-r)] and SDDs (1.96x√2xSEM) also were calculated. 
First, for the disagreement between observers within a measurement occasion, 
we used the standard deviation of the mean difference in ratings between the 
observers per movement. Second, for the disagreement among all observations 
over time (“overall”) the standard deviation of all observations per movement was 
































Assessed for eligibility (n = 260) 
Excluded after initial screening* (n = 180) 
No ischemic/hemorhragic stroke (n = 9) 
> 8 weeks poststroke (n = 28) 
Brunnstrom’s stage of recovery ! 4 (n = 169) 
Pre-existing arm impairments (n = 24) 
Planned date of discharge (n = 64) 
Refused to/could not participate (n = 6) 
Other (eg, multiple sclerosis, Alzheimer disease, locked-
in syndrome, participant in other trial, recurrent stroke) 
(n = 8) 
Unknown/missing data (n = 4) 
Excluded after inclusion testing (n = 32) 
Unable to fill out/read/understand AbilityQ (n = 9) 
Fugl-Meyer Assessment arm score >18 points (n = 14) 
Contraindications for electrical stimulation (n = 1) 
Other reasons (n = 8) 
Drop-out due to 
readmission to hospital (n = 2), 
discharge (n = 1) 
 
 
Drop-out due to 
death (n = 1), 
too much shoulder pain (n = 1) 
 
Lost to follow-up due to 
severe subluxation (n = 1), 
not willing (n = 3) 
 
Baseline 
Analyzed (n = 43 of 48)
†
 
At 4 weeks 
Analyzed (n = 39 of 45)
†, ‡ 
At 8 weeks 
Analyzed (n = 38 of 43)
§
 
At 20 weeks 
Analyzed (n = 38 of 39)� 
Figure 1   Flow of participants through each stage of the trial from initial screening by physician to follow-up 
measurement.
* If a participant was excluded for more than one reason, then all reasons were reported separately. †Five participants 
were assessed by one observer only. ‡One participant missed the four-week assessment due to poor weather 
conditions. §Four participants were assessed by one observer only, and one participant was not assessed at eight 
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Results
Figure 1 shows the flow of participants through each stage of the trial. The 
characteristics of the 48 participants are shown in Table 1. In general, they 
had restrictions in PROM for all seven arm movements, especially shoulder 
movements. They had a median score of 5.5 on the arm section of the Fugl-Meyer 
Assessment.




Age (yr), mean (SD) 57.8 (11.9)
Days after stroke, mean (SD) 44 (14.0)
Sex, no. of men/women 28 / 20
Paretic side (left/right), no.of participants 21 / 27
Stroke type (ischemic/hemorrhagic), no. of participants 39 / 9
Fugl-Meyer Assessment arm section score, median (IQR) 5.5 (4-10.75)
Shoulder PROM (degrees), mean (SD)
    External rotation 31.7 (19.4)
    Flexion 126.7 (30.6)
    Abduction 101.7 (44.1)
Elbow/forearm PROM (degrees), mean (SD)
    Extension 2.5 (7.3)b
    Supination 77.3 (11.6)
Wrist PROM (degrees), mean (SD)
    Extension with fingers extended 55.7 (17.0)
    Extension with fingers flexed 63.1 (13.0)
a IQR = interquartile range, PROM = passive range of motion
b A value of 2.5 degrees indicates elbow flexor contracture.
Figure 2 shows the separate variance components for the results obtained from 
shoulder external rotation as an example. The contribution of error variance (Table 
2) to total variance ranged from 31% (wrist extension with flexed fingers) to 50% 
(supination). The interaction of participant and time made the largest contribution to 
error variance, ranging from 59% (forearm supination) to 81% (elbow extension).Time 
made a smaller contribution to error variance, especially for shoulder movements 
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(17 %-24%) and forearm supination (19%). Time did not contribute to the variance 
in the elbow joint. The interaction between participants and observers contributed 
only marginally to error variance (0%-4%); the same was true for the main effect of 
the observers (0%-2%). Residual (unexplained) variance contributed between 7% 
and 17% to error variance, and this contribution was generally lowest for shoulder 
movements. Table 3 shows the overall interobserver reliability coefficients (and 95% 
CIs) and SEMs and SDDs in both single sessions (“observers”) and overall for the 
seven arm movements.
Discussion
When different observers independently assess a joint range that does not change 
over time, interobserver reliability generally will be good provided that standardized 
protocols17 are used and the observers are trained.30 In addition to common sources
of measurement variation, the development of contractures, hypertonia, and 
shoulder pain may complicate and negatively influence the reliability of PROM 
measurements in patients after stroke. We found that PROM assessment with 
a standardized protocol, a hydrogoniometer, and two trained observers yielded 
high interobserver reliability indexes (.89-.97) for seven arm movements. We also 
found that error variance made a large contribution (31%-50%) to the variation 
in measurement results, with the participant × time interaction being the largest 
source of variance. The SDDs ranged from 6 to 22 degrees and were largest for 
shoulder movements.
Figure 2   Variance components of shoulder external rotation. Total variance (left circle) comprised participant variance 
(main effect) and error variance. Several sources contributed to error variance. These  sources (right circle) comprised 
main effects (time and observer), interaction effects (participant × time, participant × observer, and time × observer), 



















Table 2 Estimated variance components and their contributions (in percentages) to the error variance of the 
repeated measurements of seven arm movements (n = 48).
Shoulder Wrist













Participant 385.0 1234.8 641.2 45.3 118.0 197.0 174.4
Error variance 241.3 702.2 377.1 34.4 117.8 115.5 77.9
Time 48.5 118.6 91.3 0.0a 22.3 3.2 6.5
Observer 4.5 0.3 0.7 0.0a 2.6 2.4 1.5
Participant × Observer 4.1 6.8 4.0 0.1 4.1 2.8 0.2
Participant × Time 154.8 524.1 244.6 27.7 69.6 88.7 59.4
Time × Observer 0.4 3.8 0.0a 0.6 0.8 0.4 0.0a
Residual variance 28.9 48.7 36.5 5.9 18.4 18.1 10.3
Total variance 626.4 1937.0 1018.4 79.7 235.8 312.5 252.3
% error varianceb 38.5 36.3 37.0 43.1 50.0 37.0 30.9
% contribution to error variance of:
Time 20.1 16.9 24.2 0.0 18.9 2.8 8.3
Observer 1.9 0.0 0.2 0.0 2.2 2.1 1.9
Participant × Observer 1.7 1.0 1.1 0.4 3.5 2.4 0.3
Participant × Time 64.2 74.6 64.9 80.6 59.1 76.8 76.2
Time × Observer 0.2 0.5 0.0 1.8 0.7 0.3 0.0
Residual variance 12.0 6.9 9.7 17.2 15.6 15.6 13.3
a Negative variance components (ranging between -0.027 and -0.517) were set to 0.
b Error variance expressed as a percentage of the total variance. For example, for shoulder external rotation, the 
calculation would be as follows: total variance  (626.4) minus participant variance (385.0) equals error variance 
(241.3); error variance therefore represents 38.6% of total variance.
Table 3   Interobserver reliability coeficients (and 95% Confidence Intervals), Standard Errors of Measurement (SEMs), 

































SEM (observers) 2.0 1.9 1.9 1.0 2.2 1.7 1.0
SDD (observers) 5.4 5.2 5.2 2.7 6.2 4.7 2.6
SEM (overall) 5.9 7.6 6.6 2.4 4.9 4.6 3.3
SDD (overall) 16.3 21.2 18.3 6.8 13.8 12.8 9.1
a “(Overall)” refers to the overall reliability, SEM, and SDD for the observers over time; “observers” refers to the SDD 
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and SEM for a single measurement session.
Interobserver reliability.
The interobserver reliability of our two physical therapists was high in all seven 
arm movements. These results are in concordance with previous findings.25,31 The 
reliability coefficient for shoulder abduction (.97) was higher than previously reported 
values (intraclass correlation coefficients = .84 to .87),25 and forearm supination 
resulted in the lowest reliability coefficient (0.89). Supination intraclass correlation 
coefficients were higher than previously reported values (.94 to .98),25 but the 
accompanying 95% CI’s were wider (.84 to .98). Because all of our measurements 
were obtained with the same measurement protocol,25 the values that we obtained 
may have resulted from the use of a larger sample. Differences in sample size may 
also explain the narrower 95% CIs (.89 to .95) for elbow extension measurements 
in the present study than in a recent study (0.68 to 0.97)24 of 13 patients with stroke 
and elbow flexor spasticity. Because larger samples generally yield more precise 
estimates of reliability coefficients (indicated by narrower CIs and smaller SEMs), 
the results of the present study can be interpreted with more confidence than the 
results of previous results. To our knowledge, the reliability of wrist movements 
has not been reported in patients with stroke. We found that the assessment of 
wrist extension revealed slightly higher reliability coefficients and slightly lower 
SEMs when the fingers were flexed instead of extended. The long finger flexors 
typically show increased resistance to passive stretch (hypertonia), possibly partly 
because of the rapid development of wrist flexor contractures.10,32 This condition 
occurs especially in patients with limited arm function and clearly applied to our 
participants. Therefore, wrist flexor hypertonia or contracture may have had a slight 
negative influence on the reliability of the assessments of wrist extension with 
extended fingers. This hypothesis is supported by the fact that residual variance 
(to which wrist flexor hypertonia or contracture may also have been a contributing 
factor) accounted for 16% of the error variance of the PROM measurements; when 
the fingers were flexed, the value was 13%. In conclusion, the resulting high reliability 
coefficients suggested that our standardized measurement protocol may be of use 
for other observers under comparable circumstances.
Variance components
While assessing seven arm movements on four occasions during a 20-week time 
period, we found that the participants in our sample were the largest source of 
variance. This finding indicates that the participants could be distinguished on the 
basis of their arm PROM; they had a large variety of arm joint ranges. Error variance 
explained between 31% and 50% of total variance in the PROM values. Overall, time 
and the participant × time interaction were responsible for more than 78% of the 
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variation in measurement results, with the participant × time interaction contributing 
the most. This interaction effect indicates that the effects of time on PROM of the 
arm were different in different participants, in accordance with clinical observations. 
In some participants, PROM increased over time probably as a result of natural 
neurological recovery or rehabilitation, whereas in other participants, PROM may 
have decreased over time as result of contracture formation. The main effects of time 
and observers did not contribute to the variation in the results for elbow extension 
PROM. For the latter, the participant × time interaction (81%) and random variance 
(17%) made large contributions to error variance. Clinically, this finding indicates that 
over time, elbow extension developed quite differently in the participants. Observers 
contributed only marginally to the variation in measurement results, with a maximum 
of 4% (forearm supination). This finding indicates that the differences between the 
values obtained by the two observers were small, resulting in high interobserver 
reliability coefficients. The fact that one observer performed the passive movement 
and the other positioned and read the goniometer may have led to this finding. 
On the basis of these results, we argue that arm PROM assessments with a 
hydrogoniometer in patients after stroke should be performed by two observers. 
Clinically and economically, assessments by two raters may not always be practical 
or feasible.25 Therefore, clinical and economical arguments must be weighed against 
scientific arguments (reliability) in each situation. Further research is needed to 
analyze the influence of the number of observers on measurement results. Residual 
variance in the PROM measurements in our sample may be explained partly by 
random variations in PROM over time within a participant but may also have been 
caused by random variations in the force applied by the observers or the alignment 
of the hydrogoniometer between measurements.
Smallest Detectable Differences
Overall, the SDDs ranged from 3 degrees to 22 degrees and were largest for 
shoulder movements. Taking shoulder external rotation as an example, these data 
mean that a change of 17 degrees or more over a period of 20 weeks (overall SDD) 
represents a change in PROM with 95% certainty. Physical therapists and clinicians 
can use the overall SDD to evaluate their patients’ changes in arm PROM between 
admission and discharge. Similarly, researchers can use them to interpret changes 
in participants in clinical trials. The SDDs obtained in single sessions by our two 
observers also may serve another purpose. Taking elbow extension as an example, 
our results show that a difference of more than 3 degrees between two observers 
in one session indicates a significant difference in their measurements with 95% 
certainty. In stroke research the (Modified) Tardieu Scale33 is increasingly being used 
to differentiate muscle contracture from spasticity. Because this scale relies partly 
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on PROM measurements, the SDD can be used as a threshold value that must be 
exceeded to ascertain with 95% confidence that the angles between between R1 
(“catch”) and R2 (“end range”) are significantly different and that spasticity is indeed 
present. Similarly, the overall SDD for elbow extension (7º) can be used to indicate 
significant changes in elbow PROM over longer periods of time. Comparing our 
SDDs with those reported in the literature24,25 is hindered partly by the influence of 
sample sizes on SEMs (larger samples produce smaller SEMs) and therefore SDDs 
(smaller SEMs produce smaller SDDs). Because of our larger sample, our data can 
be used to interpret differences or changes in PROM with more confidence.
Limitations
An important limitation of the present study is that half of our participants were 
allocated to a combination intervention consisting of static muscle stretch and 
electrical stimulation. Although the results of this intervention were not significantly 
different from those of a sham intervention and the variance component for 
intervention could not be estimated, we cannot rule out the possibility that the 
development of the outcomes over time was confounded by the intervention and 
therefore that the intervention contributed to residual variance. Initially, we also tried 
to verify whether shoulder pain and hypertonia of shoulder internal rotators, elbow 
flexors, and wrist flexors were sources of error variance. However, adding these 
variables to the statistical analysis led to a substantial number of unstable variance 
components. Therefore, we chose to analyze a simpler model. The best fitting model 
was subsequently applied to all other arm movements by setting all negative variances 
to 0. Future research is needed to verify which factors are actually responsible for 
random variance, for example, by comparing patients with and without contractures, 
hypertonia, and pain. Another limitation is that, despite pretrial training, we cannot 
say for certain whether the competence of our two observers had any influence on 
the study results. We selected people with stroke and poor recovery of arm motor 
control. A median score of 5.5 on the Fugl-Meyer Assessment arm section at about 6 
weeks after stroke means that a patient typically shows only hyperreflexia or (partial) 
mass synergy patterns, which are usually dominated by shoulder internal rotation 
and finger and elbow flexion, at best. Although our results can be generalized only to 
similar groups of patients, such patients represent about 36% to 52% of those with 
subacute stroke between two weeks and three months after stroke.19 Finally, our 
results may indicate reliability within observers because it is generally recognized that 
intraobserver reliability is bound to be higher than interobserver reliability.23
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This thesis focused on three separate, interrelated topics that play a role during 
the rehabilitation phase of patients after stroke. First we set out to answer the
question how often hypertonia develops in the hemiplegic elbow in the first six 
months poststroke and whether it would be possible to predict it’s development 
based on the degree of arm motor control. The second research question was 
whether static arm muscle stretching programmes would be effective in preventing 
the development of muscle contractures, hypothesizing that this would also
positively influence (or rather reduce) the development of poststroke shoulder 
pain, hypertonia / spasticity and restrictions in daily basic arm activities or arm 
motor control. Finally, we focused on the question whether passive arm joint range 
of motion (PROM), an important outcome measure used to determine the degree 
of contracture, can be assessed reliably by physical therapists. In this concluding
chapter, the main findings for these three different research topics will be
summarised, the strengths and limitations of these studies will be  discussed and 
implications for clinical practice and future research will be described.
Development of hypertonia in patients after stroke
Summary of the main results
In Chapter 2 the results of a prospective cohort study were described in which 50 
patients with a first-time ischemic stroke and an initial arm paralysis were followed 
for up to six months poststroke. The results showed that the incidence rate of 
hypertonia reached its maximum before the third month poststroke (30%). A large 
portion (42%) of the patients had hypertonia at three and six months. The study 
also revealed that participants with poor motor control, which was defined as 18 
points or less on the arm section of the Fugl-Meyer Assessment (FMA), at 48 hours 
poststroke were 13 times more likely to develop hypertonia in the first six months 
poststroke than those with FMA scores more than 18 points. Additionally, the risk 
of developing hypertonia increased significantly over time.
Discussion
The goal of the prospective cohort study was to monitor the development of
hypertonia in the flexor muscles of the hemiplegic elbow. The reason for collecting
data on hypertonia development was to check the hypothesis that stroke
survivors with poor recovery of motor control are more at risk of developing
hypertonia than those with a better level of recovery. More importantly, detailed
information about the development of hypertonia in the hemiplegic arm could serve 
to better underpin the need for interventions aimed at preventing the development 
of not only hypertonia, but also of spasticity and contractures.
Hypertonia has both a neural and a biomechanical component. Contracture is 
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an important contributor to hypertonia.1,2 This is illustrated by the finding that
increased passive muscle resistance was present independent of muscle activity 
monitored via electromyography,3 a much used electrophysiological technique 
to evaluate spasticity.4 These findings suggest that the presence of poststroke
hypertonia indirectly hints at the presence of contracture. Admittedly, it would have 
been more straightforward to monitor the development of contracture directly by 
using goniometry. In fact, the passive range of elbow motion was assessed in 31 
of the 50 participants, but unfortunately an important amount of data was missing. 
Fortunately, other authors recently directly assessed and monitored contracture 
development in the first 6 months following stroke.5 Their results showed that 52% 
of the cohort (n = 165) developed at least one contracture, that contractures were 
most common at the shoulder and the hip and more common in those with severe 
strokes (> 5 points on the National Institutes of Health Stroke Scale). Similarly, our 
results showed that 42% of our cohort (n = 50) had developed hypertonia (MAS 
≥ 1+ in the elbow flexors) and that hypertonia was more common in those with 
the poorest level of recovery of arm motor control (the latter probably being the
patients with the most severe strokes). These similarities in findings, and the fact 
that contractures are an important contributor to hypertonia suggest that the
development of hypertonia and contracture go hand in hand. More research is 
needed to determine the strength of this relationship.
Strengths and Limitations
This was the first-ever longitudinal study describing the incidence and prevalence 
of elbow flexor hypertonia in the first 6 months poststroke, and the predictive 
value of arm motor control on its development. Because hypertonia has been 
associated with serious poststroke impairments in body functions and activity
limitations, it is of paramount importance to predict and counter its development 
as soon as possible. The results of this study have not only given more insight into 
the poststroke development of hypertonia over time, but they have also shown 
that the (score on the) arm section of the Fugl-Meyer Assessment (FMA) can be 
used to predict who is most at risk of developing hypertonia: patients who score 
18 points or less on the FMA at two days poststroke have a 13 times higher risk 
of developing hypertonia in the subsequent six months. This knowledge can help 
rehabilitation clinicians and therapists to recognize patients who are at greater risk 
of developing hypertonia, so that effective preventive measures can be taken as 
soon as possible in daily clinical practice.
A limitation of this study was that only the development of elbow flexor hypertonia 
was monitored. Although hypertonia of elbow flexor muscles can impede functional 
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use of the arm (e.g. reaching with the hand, putting on a coat or sweater), hypertonia 
development of shoulder extensors, adductors, internal rotators and flexors of the 
wrist may impede arm function even more. As a consequence, the overall prevalence 
and incidence of hypertonia of the affected arm after stroke may have been
underestimated in this study. Moreover, hypertonia is commonly assessed using 
the original five-point Ashworth Scale (AS)6 or the six-point Modified Ashworth Scale 
(MAS).7 For this study the MAS was used because it was found to be reliable.7-10 
More importantly, it was selected because the MAS was the tool most used by 
other authors, which would supposedly facilitate comparison of results. Despite 
this assumption, comparison with other authors proved to be difficult. Although
most authors also used the MAS, they defined clinically relevant hypertonia
differently by choosing different cut-off levels. In the absence of agreement about 
the definition of clinically relevant hypertonia, mutual comparison of results is
hindered and general conclusions about incidence and prevalence of hypertonia 
cannot be drawn. In a sense, our choice to select yet another different cut-off 
score (1+ or higher) on the MAS during the cohort study did not contribute to 
this comparison. However, in Chapter 2 we explained this choice by arguing that 
MAS levels of 1+ or higher represents a level of clinically relevant hypertonia that 
can also be quantified biomechanically11 and which may be the minimal degree of 
hypertonia that can be associated with the development of contracture.
Implications for clinical practice and future research
Based on the excellent psychometric properties and the predictive value of the 
arm section of the FMA, we recommend that it be used routinely to assess arm 
function during poststroke rehabilitation. The advantage of the body function level 
FMA is that the motor tasks of this assessment tool can be performed by patients 
with various levels of arm motor recovery. This is not to say that the use of activity-
level arm function tests is discouraged. However, many of the motor activities of 
such widely recommended tests (e.g. the Action Research Arm Test, Wolf Arm 
Function Test, Frenchay Arm Test) require a higher level of arm motor control such 
as the ability to reach, grasp or manipulate objects. Patients with poor motor
control cannot perform such motor activities, which will repeatedly result in low 
scores on these tests, making potential small changes in arm motor control go 
unnoticed (floor effect). The FMA appears to be more sensitive to small changes, 
especially in those with poor arm motor recovery. 
Literature regarding the assessment of hypertonia clearly shows that the presence 
of resistance to passive stretch after stroke is still being considered as, and
confused with, spasticity. This is illustrated by the fact that the MAS is still widely 
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used to quantify spasticity,(eg,12) even when it has long been established that the 
MAS evaluates resistance to passive stretch caused by a combination of soft
tissue contracture and spasticity,13 and that it is unable to differentiate whether 
the cause of that resistance is neural or peripheral.14,15 Moreover, research into 
the validity and reliability of the MAS has revealed inconclusive results.eg, 10,16
A differentiation between the neural and peripheral contributions to movement
resistance can be made using the seemingly more accurate Tardieu Scale,14 but 
it’s reliability and validity has not yet been established in a population of patients 
after stroke.12 There is also lack of consensus regarding a definition of clinically 
relevant hypertonia, which we defined as a level of resistance to passive stretch 
that actually represents a degree of hypertonia that necessitates (therapeutic)
intervention. In Chapter 2 we explained our choice to select MAS scores of at 
least 1+ as a cutoff point for clinical relevant hypertonia, but this choice needs 
future verification. Many of the aforementioned uncertainties probably stem from 
a generally limited understanding of the pathophysiology of spasticity and the 
various associated neurological and biomechanical features that come into play 
after stroke.17 Although it is outside of the scope of this thesis, it is clear that future 
research is required if we are to resolve these issues.
The results of the cohort study showed that hypertonia (and therein contractures) 
developed in a large proportion of patients with stroke, predominantly within the 
first three months poststroke. The results also showed that poor arm motor control
at 48 hours poststroke is a serious risk factor for the development of hypertonia. 
Considering the problematic secondary effects of hypertonia and contracture
development, it seems to be of paramount importance to prevent these
developments as soon as possible after stroke, especially in those first three 
months.
At the beginning of the past decade, Gracies et al. already stated: “For optimal 
efficacy, therapies aimed at improving function should address both muscle
shortening and muscle overactivity; measures to relax overactive muscles should 
be combined with physical treatment to lengthen them.”18 The results from the 
cohort study suggest that this may be particularly important for those patients 
with the worst level of arm motor control, as they run the highest risk of developing
hypertonia. The efficacy of two different interventions, aimed at lengthening
overactive muscles in an attempt to prevent the development of soft tissue
changes and to minimize the level of hypertonia, are discussed in the next paragraph.
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Efficacy of treatments with static arm muscle
stretching programmes
Summary of the main results: single-modality pilot RCT
In Chapter 3 the results of a pilot randomised controlled trial (RCT), investigating 
a static arm muscle stretching programme applied as a single-modality treatment 
approach, are described. All 19 participants underwent conventional rehabilitation
care. Nine participants additionally received a static arm muscle stretching
programme for two 30-min sessions a day, five days a week, for five weeks.
Comparison of the experimental with the control participants after five weeks
showed that the additional stretching programme significantly slowed down
development of shoulder abduction contracture. Descriptive analysis of the 
10-week measurements showed further decreases of PROM in both groups. Arm 
motor control, as represented by the scores on the FMA arm section, was better 
in the experimental group at the beginning of the study, a difference that reached 
significance after five weeks. This trend seemed to continue after 10 weeks for 
the remaining participants of the experimental group, but was probably biased by 
baseline differences. The percentage of participants with pain at the end range 
of the shoulder movements remained high in both groups from baseline to 10 
weeks. Especially in the first five weeks of the trial, the participants of both groups 
gained more independence in daily life activities as indicated by the Barthel Index. 
Despite some of these positive trends, no between-group differences were found 
in resistance to passive stretch (hypertonia), arm motor control, shoulder pain or 
independence in activities of daily life. 
From a single-modality to a multimodal RCT
The results of the pilot trial were ambiguous. On the one hand, the efficacy of the 
intervention seemed to be very limited, because no between-group differences 
were found on most of the outcomes. On the other hand, the significant between-
group difference in shoulder abduction PROM seemed to suggest that the
intervention resulted in slowing down contracture development of the shoulder 
adductors. At the time that the results of the pilot trial were analyzed, a similar 
positive result was described for shoulder external rotation.19 However, the overall 
conclusion, that there was no evidence that static arm stretching programmes 
were effective, was drawn after two meta-analyses.20,21 Possible explanations for 
the lack of (statistical significant) effects were the lack of statistical power to detect 
any differences (small sample sizes) and an inadequate duration of stretching. 
These factors may also have played a role during the pilot trial. The design of 
the pilot trial was used as a blueprint for the next RCT, whereby two of the most 
probable limitations of the pilot trial were adjusted: the small sample size and the 
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possibly inadequate duration of the stretch.
The small number of participants (n = 19) that could be recruited during the pilot
trial suggested that the selection criteria were too strict. For example, several
patients were excluded for participation because they had severe neglect, loss 
of positioning sense or because they used medication for pain and spasticity. 
Furthermore, the dropout rate was high. Eventually, only 10 participants were
available for the final 10-week assessment because several participants were 
discharged before the end of the treatment period and no effort was made 
to motivate them to undergo the final measurements. During the second trial,
participants with neglect, severe loss of positioning sense and participants 
who used medication for pain or spasticity were included (Chapter 4). These
participants received extra skin checks and the use of medication was monitored. 
Also, participants with recurrent strokes were included. To minimize patient 
dropout due to discharge, the treatment period was shortened from 10 to eight 
weeks and every effort was made to motivate participants to undergo all planned
measurements even after withdrawal from the allocated intervention.
Although an inadequate duration of the stretch could be the reason for lack of an 
effect of static stretching programmes, the intensity of stretch (i.e. the force level 
at which the muscle is stretched) may also have been inadequate. To increase 
the duration of the stretching, intervention time was increased to (an expected) 
limit of workability, i.e. from 60 to 90 minutes a day. One could still argue that 
this was insufficient, especially since the Medical Disability Society recommends 
to put shortened human muscles through a full stretch for two hours in every 24 
hours.22 However, applying the stretch programme for more than 90 minutes a 
day was already considered unworkable during an intensive clinical rehabilitation 
programme. On the other hand, increasing the intensity of stretch was also taken
into consideration and subsequently achieved by making use of the muscle
stretching capabilities of another intervention. This created a multimodal approach 
to the problem. The notion of combining different treatment modalities to increase
intervention efficacy was in part derived from other fields of medicine, which
influenced the decision to combine static arm stretch positioning with an intervention 
that would preferably positively influence both the neural and biomechanical 
components of hypertonia, hence increasing the intensity of the intervention. For 
this purpose, neuromuscular electrical stimulation (NMES) was selected.
 
Summary of the main results: multimodal randomized controlled trial
In Chapter 4 the results of the second RCT, investigating a static arm muscle 
stretching programme applied in conjunction with NMES, are described. All 46 
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participants received conventional rehabilitation care. Half of the participants
(n = 23) were allocated to the experimental intervention, consisting of a static arm 
muscle stretching programme of two 45-min sessions a day, on five days a week, 
for eight weeks with simultaneous motor amplitude NMES. The control participants 
received sham arm positioning (i.e. no stretch) and sham NMES (i.e. transcutaneous 
electrical nerve stimulation with no motor effect) to the forearm only, using a similar 
frequency and duration. Despite the interventions, both groups showed similar
reductions in mean PROM across most arm joints. Shoulder pain prevalence
increased from 37% at baseline to 52% after eight weeks. Overall, pain severity
also increased, particularly on movement and at night. Improvements in the
scores of the Leeds Adult/Arm Spasticity Impact Scale and FMA over time
indicated an improved capacity to perform basic arm activities and improved arm 
motor control. Overall, the prevalence of elbow flexor hypertonia and spasticity 
jointly increased up to 55% around the eight week outcome measurement.
Despite some positive changes over time (increased motor control), no 
significant between-group differences were found in arm passive range of motion 
(contractures), shoulder pain, daily basic arm activities, hypertonia and spasticity, 
arm motor control and shoulder subluxation. 
Discussion
The results of the two RCT’s presented in this thesis cannot be discussed without
dwelling on evidence that has accumulated in literature in the past decade
regarding the effects of static arm muscle stretching programmes for the
hemiplegic arm. 
Overall, the conclusion from two meta-analyses was that static arm stretching 
programmes do not result in any clinical relevant advantages for the patients.20,21 
Some small significant effects on shoulder PROM in favour of the experimental 
groups in two of the studies suggested that the programmes could be effective
in slowing down the development of shoulder external rotation19 or shoulder
abduction (Chapter 3)23 contractures of the hemiplegic arm. However, these results 
were not confirmed by other studies. Pooled trial data resulted in a non-significant 
(p = .26) overall effect size of 1.12 with a mean difference of 2.17 degrees (95% 
CI: -1.63, 5.97) on joint mobility (range of motion) in favour of stretching.21 Few
clinicians and physical therapists would argue that a treatment effect this small 
would be clinically important. Such a small change in PROM cannot even be
assessed reliably. In fact, the minimum difference (i.e. the smallest detectable
difference) that needs to be exceeded to be 95% confident that, over time, a real 
change in passive range of motion has occurred ranges from 6 to 22 degrees for 
the different arm movements (Chapter 5 and Chapter 6). Regardless of the effects
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on joint mobility, reviewers also failed to show any effects of stretch on pain,
spasticity, and activity limitation.21 In addition, no effects were found on resistance 
to passive stretch (hypertonia), arm motor control, independence in activities of 
daily life and shoulder subluxation (Chapter 3 and Chapter 4). The interventions 
may even have resulted in adverse events because some participants from the 
experimental group showed an increase in pain,24 medication for pain and spasticity 
were prescribed more frequently and protocol compliance was lower (Chapter 
4). Although there were no significant between-group differences in pain, these 
findings may indicate that the experimental programme was not well tolerated by 
some participants. Such concerns have been raised previously.25
Strengths and Limitations
Work on the two RCT’s presented in this thesis has spanned a period of almost 
10 years. This rather long time-frame was considered an advantage since it made 
it possible to adjust the design and the statistical analyses of the multimodal trial
both according to the results of the pilot trial as well as findings in literature
published between 2003 and 2007. For example, the multimodal trial was designed 
in a period in which it became clear that a single-modality static arm stretching 
programme had very little clinical impact. As a result, a multimodal approach
for the larger RCT was chosen. Both RCT’s were designed according to the
recommendations of the CONSORT Statement.26 Thus, both RCT’s were robust in 
design. This is illustrated by the fact that the publication of the pilot trial (Chapter 3) 
has been rated with a methodological quality score of 7/10 on the PEDro-scale.27 
The experiences gained during the pilot trial enabled us to design an even more 
robust second RCT.
The research presented in Chapter 3 and Chapter 4 has contributed to the
confirmation that restrictions in range of motion of the hemiplegic shoulder and 
wrist can develop quite rapidly in patients with poor arm motor control.23,25,28,29 Our 
findings also lend support to the notion that, although TENS is commonly used to 
treat shoulder pain after stroke, there is little evidence that (in general) it is clinically 
effective in providing pain relief.30,31 We used TENS in our control group, but as 
we found no significant pain reduction both within and between the two groups, 
we are confident that we managed to select a proper sham treatment that did 
not confound the main results regarding shoulder pain. Our overall conclusions 
are also in concordance with previous results, confirming that static arm muscle 
stretching programmes cannot prevent a decrease in arm joint PROM resulting 
from contracture formation. This knowledge can be used in search of other, more 
effective interventions aimed at contracture prevention.
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The limitations specific to each of the two RCT’s have been discussed as part of 
Chapter 3 and Chapter 4. An important general limitation of the SEPP-trial was 
that an intention-to-treat analysis, the preferred analysis for an RCT, could not 
be performed. A full application of the intention-to-treat approach is possible 
only when complete outcome data are available for all randomised participants.32 
During the pilot trial, the sample sizes per group were limited, and not enough care 
was taken to follow up those patients who withdrew from the allocated treatments.
This inevitably resulted in missing data, rendering a full intention-to-treat
analysis impossible. Therefore, the clinical effectiveness of the intervention may 
have been overestimated. This specific limitation was resolved during the PAESIS-
trial. Another general limitation was that the research question, i.e. whether
sufficient muscle length would indirectly reduce the main body functions such as 
hypertonia, spasticity and shoulder pain, could not be answered because muscle 
length was not influenced by the interventions. One could argue that the lack of 
change in muscle length corresponded to a lack of change in hypertonia, spasticity 
and shoulder pain, but a causal relationship could not be demonstrated.
Implications for clinical practice and future research.
Knowledge gained during the writing of this thesis has learned that single-modality 
static arm muscle stretching programmes do not produce clinically important 
changes in joint mobility, shoulder pain, resistance to passive stretch (hypertonia), 
spasticity, arm motor control, activity limitations and independence in ADL in people
with stroke. Even a higher-intensity multimodal approach (Chapter 4) did not result
in positive effects for the patients, thereby also confirming the results of a
recent randomized trial in which a similar multimodal approach was chosen to 
prevent the development of wrist contractures.33 Some findings even suggest 
that for some participants the static arm muscle stretching programmes are not 
well tolerated. As such, the conclusion seems justified that static arm muscle
stretching programmes as described in the literature should no longer be
performed in the subacute phase following stroke. As a consequence, the stroke
rehabilitation team is left with an increasingly difficult challenge to prevent 
the development contractures, hypertonia and spasticity and its associated
secondary problems such as shoulder pain and restrictions in performance of 
daily life activities in a considerable number of patients after stroke who have poor 
motor control.
From a research perspective, it would be worthwhile to explore what renders the 
current static arm muscle stretching programmes ineffective. The finding, that this 
type of intervention does not work, raises some interesting questions.
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First of all it challenges the commonly accepted hypothesis that sustained stretch 
can improve muscle length in patients with neurological conditions in general and 
in patients after stroke in particular. Although periods of sustained stretch resulted 
in prevention of sarcomere loss and maintenance of normal passive range of
motion in animal muscles,34 connective tissue of patients after stroke does not 
seem to respond similarly to sustained stretch. It also challenges the hypothesis 
of (partial) restoration of reciprocal inhibition that has been proposed as one of the 
possible mechanisms for spasticity reduction poststroke.35,36 Especially poststroke 
patients with severe motor deficits have a higher risk of developing increased
resistance to passive muscle stretch (hypertonia) of the muscles responsible for an 
antigravity posture.5,37,38 The acting force of hypertonia may have neutralized the 
acting force of the sustained stretch, and the electrical stimulation may not have 
effectively elicited reciprocal inhibition. Future research could e.g. be aimed at
controlling the increased resistance to passive stretch during stretching or exploring 
whether reciprocal inhibition is actually restored in the subacute phase after stroke. 
Secondly, it raises the question whether an earlier start of a preventive arm muscle 
stretching programme will determine the failure or success of such an approach. 
It has been shown that there is an inverse relationship between time since onset 
of stroke and the degree of passive shoulder external rotation on the paretic side 
(Chapter 5). Results from our cohort study (Chapter 2) also showed that hypertonia 
is already present in 20% of poststroke patients at 10-12 days poststroke. These 
and other results from literature suggest that biomechanical changes develop very 
rapidly in the hemiplegic arm, and that the interventions aimed at preventing these
developments should be commenced as soon as possible after stroke,19 and
preferably before spasticity starts to emerge. As it is possible to predict who is 
most at risk of developing biomechanical adaptations (hypertonia, contracture) 
as early as 48 hours poststroke using the FMA (Chapter 2), this could also be the
appropriate starting point for these interventions.
Another explanation for the failure to show an effect of the interventions could be 
the confounding effect of the presence of shoulder pain in some of the participants. 
Although the static arm muscle stretching programme showed no overall benefits 
for the participants, some clearly developed less, and some developed more pain 
during the experiment. The data of the participants that developed more pain 
suggests that they did not tolerate the intervention well (Chapter 3). This adverse 
effect, as noted in both study groups, was not statistically different between the 
groups and there were also participants who did not develop pain and tolerated 
the programme without complications. A sensitivity analysis based on baseline 
shoulder pain might have given insight into the hypothesis that patients without 
initial shoulder pain would positively respond to this type of intervention. However, 
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such a sensitivity analysis was not deemed useful because of the resulting small 
sample sizes per group. It could be useful to investigate whether (initial) shoulder 
pain confounds the effects of static stretching. Finally, further research should 
also be performed to investigate whether other (combinations of) interventions 
can be effective. For example, it may be worth investigating whether NMES of the
muscles prone to shortening39 can be effective. It may also be worth to investigate 
the combination of static arm stretching with the simultaneous application of 
heat or transcranial magnetic stimulation (TMS). Both heat and TMS are ‘passive’
interventions that can be used to treat patients who lack active arm motor control. 
Recent research has shown that heat can be an effective adjunct to developmental
and therapeutic stretching techniques40,41 and that TMS may create a
homeostatic change in the brain which contributes to the normalization of muscle 
tone and induce arm movement.42 Lastly, to save valuable treatment time, a
triple combination of interventions can be considered. This is a common approach 
in medicine research and has resulted in positive results e.g. in the treatment of 
hypertension.43
One of the key goals of the static arm muscle stretching programme was to
prevent the development of shoulder and arm contractures. To quantify this
outcome, the PROM of several arm movements was assessed on several
occasions using a (hydro)goniometer. Although overall the intervention did not 
produce any clinical relevant advantages for the patients, some results suggested that
contracture development could be slowed down. For example, after eight weeks 
of positioning, the experimental participants of the multimodal trial had a statistically 
significant larger shoulder external rotation PROM of 13 degrees (95%CI 1-24) 
compared to the control participants (Chapter 4). It is of note that this specific
result was based on a single t-test at eight weeks, and not on the original multilevel 
regression analysis. Despite that, it would still be interesting to ascertain whether 
a between-group difference of this magnitude would represent a clinically relevant
difference in PROM. Additionally, for the interpretation of the study results of 
the two RCT’s, it was vital that the (hydro)goniometer was able to precisely and
accurately assess changes in PROM. Previous studies have shown that goniometry 
is prone to error, and reliability both changes from joint to joint and depends on 
multiple factors. As a consequence, each time PROM results are presented, the 
question remains as to whether these measurements are reliable, are influenced 
by different sources of variation and whether changes in PROM found represent 




Assessment of the reliability of goniometric passive 
range of motion measurements of the hemiplegic arm
Summary of the main results
The results of the two separate reliability studies, during which five (Chapter 5) 
and seven (Chapter 6) arm movements were assessed on three and four different
occasions, respectively, showed that the assessment of PROM yielded high levels 
of agreement between the observers with intraclass correlation coefficients (ICC’s) 
ranging between 0.84 and 0.99. Smallest detectable differences (SDD’s) were 
largest for the shoulder movements. Correlations revealed that restricted range of 
arm motions relate to the time poststroke and coincide with pain, but concurrent
validity with the Ashworth Scale, Fugl-Meyer Assessment and Barthel Index
scores was limited (Chapter 5). The PROM measurements were influenced by
error variance ranging from 31% to 50%. The participant × time interaction made 
the largest contribution to error variance, ranging from 59% to 81% (Chapter 6). 
Discussion
At the beginning of this century, little was known about PROM measurements in 
the hemiplegic arm: literature regarding the reliability of goniometric measurements 
was scarce, information about smallest detectable differences (SDD) was lacking, 
factors associated with range of motion measurements (such as hypertonia and 
shoulder pain) as indicators of their concurrent validity were unknown and research 
into factors that might potentially influence hemiplegic arm PROM measurements 
had never been performed. The research presented in Chapter 5 and Chapter 6 of 
this thesis has contributed to filling these gaps in knowledge. First we established 
that PROM measurements with a hydrogoniometer can be performed reliably by 
two different raters (Chapter 5).44 This finding was confirmed using a larger sample 
(Chapter 6),45 and this time the results also indicated that the differences between 
the raters’ values were so small that they only contributed marginally to the variation 
in measurement results. Although other authors already showed that shoulder 
external rotation46 and elbow extension47 PROM could be assessed reliably, the 
added value of our studies is that the same has been shown to be true for shoulder 
abduction and flexion, forearm pronation, wrist extension and wrist flexion with 
extended and flexed fingers. Second, our work has yielded data that clinicians, 
therapists and researchers can use to judge whether the changes in arm PROM of 
their poststroke patients or participants represent real changes in PROM with 95% 
certainty. For example, when a therapists aims to improve shoulder abduction
PROM during rehabilitation and uses a hydrogoniometer to assess these changes,
he or she can now know that changes between 0 and 21 degrees over 20 weeks of 
time may well be the result of random measurement errors and not even represent 
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a reliable change in PROM. The SDD’s can also serve researchers of intervention 
trials in predetermining the clinically relevant difference in PROM: they must make 
sure that it exceeds the SDD for that particular arm movement if they want to be 
95% sure that the change does not reflect the measurement error. 
Strengths and limitations
Comparison of our results with the limited information in literature is partly hindered 
by the differences in sample sizes. Small sample sizes will yield an imprecise estimate 
of the reliability coefficients which is indicated by an excessively wide confidence 
interval.48 Although the sample was limited to a maximum of 18 participants 
during the first reliability study (Chapter 5), results from the second study with 48 
participants (Chapter 6) were in line with the first and previously published findings. 
The results from the second study also showed that the observers only contributed 
marginally to the variation in measurement results (maximum of 4%), indicating that 
the differences between the values of the two observers were small, and resulting 
in high inter-observer reliability coefficients. The fact that one observer performed 
the passive movement while the other positioned and read the goniometer may 
have led to these excellent results. Because we used larger sample sizes than in 
previous work, our results can be interpreted with more confidence.
Some limitations of the reliability studies have been discussed as part of Chapter 
5 and Chapter 6, but some minor limitations remain. Several patients dropped out 
during the pilot trial, resulting in only 12 participants with full datasets for one proper
analysis of variance. To compensate for the loss of participant data over the 
course of the trial, the decision was made to calculate the ICC’s for three different
datasets that represented the three different evaluation moments of the main trial. 
This approach introduced dependency in the data, and the analysis of different 
sample sizes resulted in varying standard errors of measurement, a less precise 
estimate of the reliability coefficients and wider confidence intervals. The issue 
of patient dropout was more or less resolved during the second study, resulting 
in a more robust analysis. Also, in the first study44 the SDD’s were interpreted as 
‘overall’, whereas they should have been interpreted as ‘observer’ SDD’s as during 
the second study. 
Implications for clinical practice and future research.
Overall, the good results of the two reliability studies during the RCT’s suggest that 
our standardized measurement protocol may be of use for other observers under
comparable circumstances, either during research projects or in daily clinical practice. 
This does imply that two assessors should be used during arm PROM measurements. 
7 7
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This may not always be practical and feasible in clinical practice because it may 
involve higher costs. It is therefore suggested to perform a study that investigates 
the reliability of arm PROM measurements comparing one rater versus two raters 
working together. In view of this, it may be worthwhile to assess the reliability 
of, for example, smartphone-based goniometric measurements in patients after 
stroke, provided that the goniometer can be strapped onto the patient’s limb(s) so 
that the rater can focus on passively moving the arm without having to worry about 
aligning the goniometer and reading the measurement all simultaneously. Such 
devices could potentially limit sources of variation to the measurement results (e.g. 
alignment errors, reading errors) and hence improve the reliability of the measurements. 
Until research using one rater has been performed we argue that, at least during 
research, arm PROM assessments with a hydrogoniometer in patients after stroke 
should be performed by two trained observers. Finally, future research could also 
be aimed at investigating whether factors such as the number and competence 
of the observers, as well as hypertonia and shoulder pain are sources of variation 
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A considerable number of people who have suffered a cerebrovascular accident 
(CVA) or stroke lose the ability to use their involved arm for functional activities. The 
lack of recovery and the subsequent immobilisation make the arm prone to the 
development of complications secondary to stroke such as hypertonia, muscle 
contractures and shoulder pain. These impairments in body functions threaten the 
long-term handling and assistive use of the affected arm.
Chapter 2 of this thesis describes an investigation into the incidence and
prevalence of hypertonia poststroke, and the predictability of the degree of arm 
motor control on its development. In Chapter 3 the efficacy of a single-modality 
static arm muscle stretching programme is explored. This intervention aimed 
to prevent the development of hypertonia, contractures and other secondary
complications in the poorly recovered hemiplegic arm. In Chapter 4 the results of 
a multimodal intervention, consisting of a static arm muscle stretching programme 
combined with neuromuscular electrical stimulation, are presented. An important 
outcome measure in both these randomised controlled trials was the degree of 
change in passive range of motion (PROM) of selected arm joints. Information 
about observer reliability, smallest detectable differences and factors that are
associated with, or influence the PROM measurements, are the focus of Chapter 5 
and Chapter 6. The general discussion in Chapter 7 summarises the individual 
studies and their results, and addresses the strengths, limitations and implications 
for future research and clinical practice.
The introductory chapter of this thesis describes some of the most common 
impairments in body functions a patient can develop after stroke. Often, 
the negative and positive motor signs of the upper motor neurone syndrome 
render the hemiplegic arm inactive and immobilised, and impede voluntary motor 
actions. Two significant consequences of these motor signs are that the muscles 
have a tendency to remain in a shortened position for prolonged periods of time, 
and that attempted voluntary movements are restricted. Prolonged periods of 
both muscle spasticity and immobilisation can result in the development of arm 
muscle contractures. Contractures result in stiffer muscles and are associated 
with the development of hemiplegic shoulder pain. The combination of spasticity 
and contractures leads to increased resistance to passive stretch, also known as 
hypertonia.
In Chapter 2, a prospective cohort study is described in which 50 patients with a 
first-time ischemic stroke and an initial arm paralysis were followed for six months. 
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The results showed that the incidence rate of hypertonia of the elbow flexors 
reached its maximum before the third month (30%). A large portion (42%) of the 
patients presented hypertonia at three and six months. The study further showed 
that participants with poor motor control (with a maximum of 18 points on the arm 
section of the Fugl-Meyer Assessment) at 48 hours poststroke, were 13 times 
more likely to develop hypertonia in the first six months than those with moderate 
to good arm motor control (more than 18 points). Additionally, the risk of developing 
hypertonia increased significantly over time.
Because contracture is considered to be an important contributor to hypertonia, 
and hypertonia has been associated with serious poststroke impairments in body 
functions and activity limitations, it is deemed of paramount importance to predict 
and counter its development as soon as possible. Literature also suggests that 
there are bidirectional relationships between hypertonia/spasticity, contracture 
and hemiplegic shoulder pain. As such, interventions aimed at the prevention of 
muscle contracture development may in turn result in the prevention of the development 
of hypertonia/spasticity and shoulder pain.
In Chapter 3, a pilot randomised controlled trial (n = 19) is described in which 
the efficacy of a single-modality intervention, aimed at preventing arm muscle 
contracture development, was investigated. The results showed that the PROM of 
five arm movements decreased over time. Nine participants of the experimental 
group received an additional arm muscle stretching programme of 60 minutes per
working day for five weeks. There was some evidence that the intervention 
significantly slowed down the development of shoulder abduction contracture (p 
= .042, -5.3 degrees versus -23 degrees). However, the study was underpowered, 
and no effects were found in resistance to passive stretch (hypertonia), arm motor 
control, shoulder pain or independence in activities of daily life. Upon publication 
of these results, other literature confirmed that single-modality static arm stretching 
programmes do not result in any clinical relevant advantages for patients. Possible 
explanations for the lack of effect were the inadequate duration and intensity of 
the stretch.
In Chapter 4, a randomised controlled trial is described in which the efficacy of 
a higher-intensity multimodal intervention for arm contracture development was 
investigated. The results of this larger trial (n = 48) showed that performing a static 
arm muscle stretching programme for 90 minutes per working day combined with 
simultaneous administration of an electrically induced stretching exercise (using
neuromuscular electrical stimulation), did not result in an increase in PROM.
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Despite some positive, but clinically non-relevant changes over time (increased 
motor control), there were also no effects on shoulder pain, daily basic arm 
activities, hypertonia and spasticity, arm motor control and shoulder subluxation.
The results of the two randomized controlled trials described in this thesis confirm 
the conclusions of other authors, and suggest that it is not possible to control or 
overcome (the emergence of) contractures and hypertonia in patients with poor 
arm motor control after stroke by using the current static arm muscle stretching 
programmes. Therefore, such programmes should no longer be performed 
in the subacute phase following stroke. Consequently, the rehabilitation team 
is left with an increasingly difficult challenge to prevent the development of 
contractures, hypertonia/spasticity and its associated secondary complications in 
a considerable number of patients after stroke.
One of the key goals of the static arm muscle stretching programmes was to 
prevent the development of shoulder and arm contractures, as reflected by a
decrease in PROM. To quantify this outcome, the PROM of several arm movements 
was assessed on multiple occasions using a (hydro)goniometer. In Chapter 5 and 
Chapter 6, the questions are answered whether our PROM measurements were 
reliable and influenced by different sources of variation as well as what magnitude 
of change in PROM represent clinically important changes. The overall results 
showed that the assessment of PROM yielded high levels of agreement between 
the observers, with intraclass correlation coefficients ranging between 0.84 and 
0.99. These results suggest that our standardised measurement protocol may be 
of use for other observers under comparable circumstances, provided that two 
trained observers are used. Correlations have revealed that restricted range of 
arm motions are associated with the time poststroke and coincide with pain, but 
concurrent validity with assessments of hypertonia (Ashworth Scale), arm motor
control (Fugl-Meyer Assessment), and performance of activities of daily life
(Barthel Index) have shown to be limited. The PROM measurements were
influenced by error variance, ranging from 31% to 50%. Participant × time interaction 
made the largest contribution to error variance, ranging from 59% to 81%. The 
observers contributed only marginally to the variation in measurement results 
(maximum of 4%), resulting in high interobserver reliability coefficients. The results 
regarding the smallest detectable differences presented in these two chapters can 
be used by clinicians, therapists and researchers to judge whether the changes in 
arm PROM of their poststroke patients or participants represent real changes in 
PROM with 95% certainty.
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Chapter 7 critically reflects on the results, strengths, and limitations of the studies 
that are presented in this thesis. Implications for clinical practice and future research 
are also described. In summary, it seems clear that hypertonia develops in a
considerable number of patients poststroke, and that its risk of development can 
be predicted at 48 hours poststroke using the score on the arm section of the 
Fugl-Meyer Assessment. However, final conclusions about the negative impact 
of hypertonia in this patient group can only be drawn when the development of 
hypertonia in more muscle groups (and not just elbow flexors) is monitored, and 
when there is a clear consensus about the definition of clinically relevant hypertonia. 
It seems to be of paramount importance to prevent the development of hypertonia 
and contractures as soon as possible poststroke, especially for those patients 
with the poorest level of arm motor control. An investigation into the efficacy of 
two ‘passive’ interventions, that were aimed at lengthening overactive muscles 
and preventing the development of soft tissue changes, has not resulted in any 
clinical relevant advantages for the patients. Explanations for the lack of efficacy 
were the relatively late start or insufficient intensity of the interventions. The results 
challenge the hypotheses that sustained stretch can improve muscle length, and 
that reciprocal inhibition is restored in patients after stroke. Finally, the reliability of 
the PROM-measurements that were performed during the two RCT’s were shown 
to be good. The standardised measurement protocol that was used may be of use 
for other observers under comparable circumstances, although PROM assessments 
by two observers may not always be practical and feasible. Future research using 





Een groot aantal patiënten dat een beroerte (cerebrovasculair accident, CVA) heeft 
doorgemaakt, verliest de mogelijkheid om hun aangedane, verlamde arm in te 
schakelen voor functionele activiteiten. Door het gebrek aan motorisch functieherstel 
blijft de arm het grootste deel van de tijd geïmmobiliseerd. Als gevolg hiervan kunnen 
zich CVA-specifieke secundaire functiestoornissen ontwikkelen zoals hypertonie, 
spierverkortingen (contracturen) en schouderpijn. Deze functiestoornissen beïnvloeden 
motorisch herstel in negatieve zin.
In Hoofdstuk 2 van dit proefschrift wordt een onderzoek beschreven naar de
incidentie en prevalentie van hypertonie bij patiënten na een eerste CVA. Daarnaast 
is onderzocht in hoeverre deze negatieve ontwikkeling is te voorspellen op basis 
van de mate van ontwikkeling van de armmotoriek. In Hoofdstuk 3 is de effectiviteit 
van een contractuur-preventieve rekhouding beschreven voor CVA-patiënten die 
een slecht motorisch herstel van de armfunctie hebben. Deze interventie heeft als 
doel om de ontwikkeling van hypertonie, contracturen en bijkomende secundaire 
functiestoornissen in de revalidatiefase na het CVA te voorkomen. In Hoofdstuk 4 
worden de effecten beschreven van onderzoek naar de effecten van een preventieve
rekhouding in combinatie met neuromusculaire elektrostimulatie. Eén van de
belangrijkste uitkomstmaten die tijdens deze gerandomiseerde effectstudies werd 
gebruikt was de passieve bewegingsuitslag (passieve range of motion, PROM) van 
de aangedane armgewrichten. De betrouwbaarheid van deze PROM-metingen, 
alsmede factoren die van invloed waren op de betrouwbaarheid, zijn de belangrijkste 
onderwerpen van Hoofdstuk 5 en Hoofdstuk 6. Hoofdstuk 7 vormt tenslotte
de algemene discussie van dit proefschrift. Hierin wordt gereflecteerd op de
bevindingen uit de verschillende voorgaande hoofdstukken.
In het eerste hoofdstuk van dit proefschrift worden enkele van de meest voorkomende 
functiestoornissen of symptomen beschreven die een patiënt na het doormaken van
een beroerte kan ontwikkelen. De zogenoemde ‘negatieve’ en ‘positieve’ symptomen 
die tot uiting komen na hersenletsel zijn er vaak de oorzaak van dat bepaalde
spieren spastisch worden, dat de hemiplegische arm niet of niet goed kan
bewegen en dat de spieren van de verlamde arm langduring in een verkorte positie 
worden gehouden. Wanneer een halfzijdig verlamde arm langdurig geïmmobiliseerd 
blijft zullen zich op den duur contracturen ontwikkelen. Contracturen veroorzaken 
stijfheid in spieren en lijken gerelateerd te zijn aan de ontwikkeling van schouderpijn.
De combinatie van spasticiteit en contracturen leidt tot een verhoogde weerstand bij 
passief bewegen van spieren. Dit fenomeen wordt hypertonie genoemd.
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Hoofdstuk 2 geeft de resultaten van een prospectief cohort onderzoek weer.
Tijdens dit onderzoek werden 50 acute CVA-patiënten, die bij opname in het
ziekenhuis een afunctionele arm hadden, tot zes maanden na hun beroerte gevolgd. 
De incidentie van hypertonie in de buigspieren (flexoren) van de elleboog bereikte 
het maximum (30%) op drie maanden na het CVA. Op drie en zes maanden na 
het CVA bedroeg de prevalentie 42%. De studie heeft tevens aangetoond dat 
patiënten met een slecht herstel van de armfunctie (d.w.z. met een maximum van 
18 punten op de Fugl-Meyer Assessment armscore, FMA) op 48 uur na het CVA 
een 13 keer hogere kans hadden op het ontwikkelen van hypertonie dan patiënten 
met een redelijk tot goede armfunctie (d.w.z. meer dan 18 punten op de FMA). 
Bovendien nam de kans op het ontwikkelen van hypertonie toe naarmate de tijd 
vorderde.
Spieren die verkorten worden ook stijver. De stijfheid van deze verkorte spieren 
draagt in belangrijke mate bij aan de algehele verhoogde weerstand bij het bewegen 
van spieren en gewrichten. Omdat hypertonie negatief samenhangt met verscheidene 
functiestoornissen en beperkingen in activiteiten van de arm, wordt aangegeven 
dat het zeer belangrijk is om deze ontwikkeling zo spoedig mogelijk na het ontstaan 
van een CVA te voorspellen en tegen te gaan. De wetenschappelijke literatuur op
dit gebied suggereert tevens dat hypertonie/spasticiteit, contracturen en schouderpijn 
onderling samenhangen. Vanuit die hypothese zou het mogelijk moeten zijn om 
de ontwikkeling van hypertonie/spasticiteit en schouderpijn te voorkomen door 
primair het ontstaan van contracturen te voorkomen.
Hoofdstuk 3 beschrijft een gerandomiseerde pilotstudie (n = 19) waarin de effectiviteit 
van het toepassen van een contractuur-preventieve rekhouding voor CVA-patiënten 
is onderzocht. De resultaten hebben o.a. aangetoond dat de PROM van vijf 
verschillende armbewegingen in vijf weken tijd langzaam verslechterden. Om dit tegen 
te gaan voerden negen CVA-patiënten, naast de reguliere revalidatiebehandeling, 
vijf weken lang dagelijks 60 minuten de rekhouding uit. Er werden aanwijzingen
gevonden dat het uitvoeren van deze preventieve behandeling de achteruitgang 
van de mogelijkheid om de arm zijwaarts te heffen (passieve abductie van de 
schouder) afremde (p = .042, -5.3 graden versus -23 graden). De onderzoekspopulatie 
was echter slechts van bescheiden omvang en er werden geen verschillen tussen 
de groepen gevonden op het gebied van hypertonie, de willekeurige motoriek van 
de arm, schouderpijn en onafhankelijkheid in activiteiten van het dagelijkse leven. 
Ten tijde van de publicatie van deze resultaten werden deze bevindingen bevestigd 
door verschillende andere onderzoekers. Hieruit werd de conclusie getrokken dat 
deze enkelvoudige vorm van contractuurpreventie geen klinische meerwaarde 
128
had voor de patiënten. Redenen voor het gebrek aan effectiviteit zouden kunnen 
zijn gelegen in een onvoldoende duur en intensiteit van de rek op de arm- en 
schouderspieren. Dit vormde de aanleiding voor het doen van vervolgonderzoek.
In Hoofdstuk 4 wordt een gerandomiseerde effectstudie beschreven waarin voor 
een langere duur en een hogere intensiteit van de rekhouding werd gekozen.
Tijdens dit onderzoek voerden 23 CVA-patiënten, naast de reguliere revalidatie-
behandeling, acht weken lang dagelijks 90 minuten de rekhouding uit in combinatie
met het toepassen van gelijktijdige neuromusculaire elektrostimulatie. De 23
patiënten uit de controlegroep kregen een nepbehandeling (placebo) van gelijke
duur. Ondanks enkele positieve veranderingen over de tijd werden er na acht
weken geen verschillen tussen beide groepen gevonden in de PROM, schouderpijn, 
armfunctie, hypertonie en spasticiteit, de ontwikkeling van willekeurige motoriek van 
de arm en subluxatie van de schouder.
De resultaten van de twee RCT’s die zijn beschreven in dit proefschrift komen 
overeen met de resultaten van vergelijkbare studies die worden beschreven in de 
literatuur. Hieruit kan de conclusie worden getrokken dat het, met de contractuur-
preventieve rekhoudingen in de huidige vorm, niet mogelijk is om de ontwikkeling 
van contracturen en hypertonie tegen te gaan of te verminderen. Daarom lijkt het 
logisch om het gebruik van deze behandelvorm niet (meer) aan te bevelen in de 
(subacute) revalidatiefase fase na een CVA. De consequentie hiervan is dat het 
team van hulpverleners rond de CVA patiënt geconfronteerd blijft worden met de 
uitdaging om de ontwikkeling van contracturen, hypertonie/spasticiteit en daaraan 
gerelateerde functiestoornissen en beperkingen in activiteiten tegen te gaan.
Een belangrijk doel tijdens de studies naar de effecten van de experimentele
rekhoudingen was om de afname van de PROM van de armgewrichten tegen te 
gaan. Om deze variabele te kwantificeren werden de passieve armbewegingen 
door twee fysiotherapeuten gemeten met behulp van een (hydro)goniometer. In 
Hoofdstuk 5 en Hoofdstuk 6 zijn de vragen beantwoord in hoeverre de PROM-
metingen van deze fysiotherapeuten betrouwbaar waren en in hoeverre deze
metingen werden beïnvloed door verschillende bronnen van variatie. De resultaten 
hebben laten zien dat de twee fysiotherapeuten hun metingen zeer betrouwbaar 
hebben uitgevoerd (intraclass correlatie coëfficiënten tussen de 0.84 en 0.99). 
Hiermee is duidelijk geworden dat het gehanteerde gestandaardiseerde meetprotocol 
ook geschikt is voor gebruik door andere therapeuten onder vergelijkbare 
omstandigheden, met dien verstande dat er twee beoordelaars worden gebruikt. 
De PROM metingen werden wel beïnvloed door error variatie, welke varieerde 
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van 31% tot 50%. De interactie tussen patiënt en tijd (variërend van 59% tot 81%) 
droeg voor een groot deel bij aan deze error variatie. De beoordelaars zelf droegen 
slecht in zeer geringe mate (4%) bij aan de variatie in meetresultaten (4%), hetgeen 
resulteerde in de hoge betrouwbaarheidscoëfficiënten. De gevonden waarden van 
de smallest detectable differences die in deze twee hoofdstukken zijn gepresenteerd
bieden clinici, therapeuten en onderzoekers de mogelijkheid om met 95%
zekerheid te kunnen bepalen hoe groot veranderingen in de beweeglijkheid van 
de arm- en schoudergewrichten minimaal moeten zijn om er zeker van te zijn 
dat deze ook daadwerkelijk een significante verandering representeren. Tot slot is
aangetoond dat er een relatie bestaat tussen de afname van de PROM en de 
tijd die is verstreken na het CVA, alsmede het optreden van pijn. De concurrente
validiteit met de metingen van hypertonie (de Ashworth Schaal), willekeurige
motoriek van de arm (Fugl-Meyer Assessment) en de uitvoer van activiteiten in het 
dagelijkse leven (Barthel Index) bleken echter zeer beperkt. 
In Hoofdstuk 7 wordt kritisch gereflecteerd op de resultaten en de sterke en zwakke 
punten van de verschillende studies. Tevens wordt stilgestaan bij de implicaties die 
de resultaten van deze studies hebben voor de dagelijkse praktijk. Tot slot worden
enkele aanbevelingen gedaan voor toekomstig onderzoek. Samenvattend kan
geconcludeerd worden dat hypertonie zich ontwikkelt in een aanzienlijke groep 
van CVA-patiënten en dat deze ontwikkeling al op 48 uur na het CVA voorspeld 
kan worden op basis van de score op Fugl-Meyer Assessment. De negatieve
impact die de ontwikkeling van hypertonie op CVA-patiënten heeft kan echter nog 
veel accurater worden beoordeeld als deze gelijktijdig in meerdere spiergroepen 
(en niet alleen in de flexoren van de elleboog) wordt gemonitord en wanneer er 
consensus wordt bereikt over de definitie van klinisch relevante hypertonie. Voorts 
is stilgestaan bij de redenen waarom het belangrijk is om bij CVA-patiënten, die 
een slecht herstel van de armfunctie vertonen, de ontwikkeling van contracturen 
en hypertonie zo spoedig mogelijk na het CVA te voorkomen. Deze negatieve 
ontwikkeling is getracht te voorkomen middels twee experimentele interventies.
De interventies bestonden uit het 60 minuten per dag rekken van arm- en
schouderspieren die neigen tot verkorten, of 90 minuten per dag rekken in 
combinatie met neuromusculaire elektrostimulatie van enkele tegenoverliggende 
spieren (antagonisten). Helaas hebben deze interventies niet geleid tot klinisch 
bruikbare resultaten. Verklaringen die kunnen worden gegeven voor het gebrek 
aan effect zijn de relatief late start van de interventie en een onvoldoende intensiviteit 
van de interventies. De resultaten van deze studies betwisten de gangbare
hypotheses dat klinisch relevante contracturen tegengegaan dan wel verminderd 
kunnen worden met statische (duur)rek en dat het mechanisme van reciproke
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inhibitie na een CVA kan herstellen. Tot slot bleek de betrouwbaarheid van de PROM-
metingen tijdens de interventiestudies zeer goed te zijn. Het daarbij gehanteerde
meetprotocol kan van nut zijn voor andere beoordelaars onder vergelijkbare
omstandigheden. Het is wel de vraag of het gebruik van twee meettherapeuten
efficiënt is. Vervolgonderzoek zal moeten uitwijzen of het gebruik van één beoordelaar 
tot vergelijkbare dan wel betere resultaten zal leiden.     
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